header logo image


Page 337«..1020..336337338339..350360..»

Biology is having its industrial revolution – Axios

October 25th, 2020 5:56 am

Bioscience research is undergoing a wave of automation and digitization, turning a manual, laborious practice into a true industry.

Why it matters: Biotechnology promises to revolutionize everything from medicine to energy, but for that to happen, the field needs to move out of the traditional lab and into something resembling a foundry. The growth of robotics and cloud-based remote research can help make that happen.

What's happening: In a report published last week, the design and engineering firm Arup made the case that the future of scientific labs will increasingly be automated and digitized, allowing researchers to carry out experiments remotely and scale up their work faster.

How it works: That means labs where experiments can be automated think robot arms moving vials en masse, rather than overworked graduate students pipetting by hand.

Of note: Benchling, which helps life science researchers remotely track and share data, has seen a 35% increase in platform use from customers working on COVID-19.

Zoom in: Speed and industrialization in the lab are particularly vital for developing a COVID-19 vaccine in record time.

Context: Ginkgo Bioworks, which is now valued at more than $4 billion, represents the cutting edge of biotech industrialization.

What's next: On Tuesday, the Department of Defense announced it would award $87.5 million which will be matched by more than $180 million in non-federal funding to establish a manufacturing innovation institute called BioMADE at the University of Minnesota.

The bottom line: If the 21st century really is going to be the "age of biology," as some experts have predicted, the field needs to undergo its own version of the Industrial Revolution.

See the article here:
Biology is having its industrial revolution - Axios

Read More...

Is Adaptimmune Therapeutics PLC – ADR (ADAP) a Winner in the Biotechnology Industry? – InvestorsObserver

October 25th, 2020 5:56 am

The 55 rating InvestorsObserver gives to Adaptimmune Therapeutics PLC - ADR (ADAP) stock puts it near the middle of the Biotechnology industry. In addition to scoring higher than 64 percent of stocks in the Biotechnology industry, ADAPs 55 overall rating means the stock scores better than 55 percent of all stocks.

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.

This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

Adaptimmune Therapeutics PLC - ADR (ADAP) stock has risen 12.79% while the S&P 500 is down -0.07% as of 11:50 AM on Friday, Oct 23. ADAP has gained $0.55 from the previous closing price of $4.30 on volume of 879,311 shares. Over the past year the S&P 500 is up 14.64% while ADAP has gained 444.94%. ADAP lost -$1.10 per share the over the last 12 months.

Click Here to get the full Stock Score Report on Adaptimmune Therapeutics PLC - ADR (ADAP) Stock.

See the rest here:
Is Adaptimmune Therapeutics PLC - ADR (ADAP) a Winner in the Biotechnology Industry? - InvestorsObserver

Read More...

Is Cardiff Oncology Inc (CRDF) a Winner in the Biotechnology Industry? – InvestorsObserver

October 25th, 2020 5:56 am

Cardiff Oncology Inc (CRDF) is around the top of the Biotechnology industry according to InvestorsObserver. CRDF received an overall rating of 89, which means that it scores higher than 89 percent of all stocks. Cardiff Oncology Inc also achieved a score of 99 in the Biotechnology industry, putting it above 99 percent of Biotechnology stocks. Biotechnology is ranked 31 out of the 148 industries.

Finding the best stocks can be tricky. It isnt easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObservers tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObservers overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. Theres no need to try to remember what is good for a bunch of complicated ratios, just pay attention to which numbers are the highest.

Cardiff Oncology Inc (CRDF) stock is trading at $13.30 as of 11:34 AM on Thursday, Oct 22, a gain of $1.28, or 10.65% from the previous closing price of $12.02. The stock has traded between $12.50 and $13.41 so far today. Volume today is below average. So far 427,977 shares have traded compared to average volume of 3,743,546 shares.

Click Here to get the full Stock Score Report on Cardiff Oncology Inc (CRDF) Stock.

See the original post here:
Is Cardiff Oncology Inc (CRDF) a Winner in the Biotechnology Industry? - InvestorsObserver

Read More...

Covid-19 Impact On Pharmaceutical & Biotechnology Environmental Monitoring Market : Growth, Segmentation Analysis By Application And Regions To…

October 25th, 2020 5:56 am

Pharmaceutical & Biotechnology Environmental Monitoring Market 2020: Latest Analysis

Chicago, United States:- Global Pharmaceutical & Biotechnology Environmental Monitoring Market reports offers important insights which help the industry experts, product managers, CEOs, and business executives to draft their policies on various parameters including expansion, acquisition, and new product launch as well as analyzing and understanding the market trends.

Each segment of the global Pharmaceutical & Biotechnology Environmental Monitoring market is extensively evaluated in the research study. The segmental analysis offered in the report pinpoints key opportunities available in the global Pharmaceutical & Biotechnology Environmental Monitoring market through leading segments. The regional study of the global Pharmaceutical & Biotechnology Environmental Monitoring market included in the report helps readers to gain a sound understanding of the development of different geographical markets in recent years and also going forth. We have provided a detailed study on the critical dynamics of the global Pharmaceutical & Biotechnology Environmental Monitoring market, which include the market influence and market effect factors, drivers, challenges, restraints, trends, and prospects. The research study also includes other types of analysis such as qualitative and quantitative.

Global Pharmaceutical & Biotechnology Environmental Monitoring Market report offers a detailed Outlook and future prospects of the Industry. The Pharmaceutical & Biotechnology Environmental Monitoring Market report includes various topics like market size & share, Product types, applications, key market drivers & restraints, challenges, growth opportunities, key players, competitive landscape.

Top Players of Pharmaceutical & Biotechnology Environmental Monitoring Market are Studied: Danaher Corporation, Thermo Fisher Scientific, Merck KGaA, Eurofins Sinensis, Lonza, Biomerieux, VAI, Cosasco, RMONI, Amphenol Advanced Sensors, Vaisala

Download Free Sample PDF (including full TOC, Tables, and Figures) of Pharmaceutical & Biotechnology Environmental Monitoring Market Research 2020-2026:- @

Competitive landscape is a critical aspect every key player needs to be familiar with. The report throws light on the competitive scenario of the global Pharmaceutical & Biotechnology Environmental Monitoring market to know the competition at both the domestic and global levels. Market experts have also offered the outline of every leading player of the global Pharmaceutical & Biotechnology Environmental Monitoring market, considering the key aspects such as areas of operation, production, and product portfolio. Additionally, companies in the report are studied based on the key factors such as company size, market share, market growth, revenue, production volume, and profits.

NOTE:Due to the pandemic, we have included a special section on the Impact of COVID 19 on the Pharmaceutical & Biotechnology Environmental Monitoring Market which would mention How the Covid-19 is Affecting the Pharmaceutical & Biotechnology Environmental Monitoring Industry, Market Trends and Potential Opportunities in the COVID-19 Landscape, Covid-19 Impact on Key Regions and Proposal for Pharmaceutical & Biotechnology Environmental Monitoring Players to Combat Covid-19 Impact.

Environmental monitoring during pharmaceutical and biopharmaceutical production is crucial for ensuring the safety of formulated drug products. While requirements for the control of both viable (living microorganisms) and non-viable particles (e.g. dust, hair, etc.) and other contaminants (i.e. trace metals, volatiles, etc.) for aseptic manufacturing operations are more extensive than those for non-sterile processes, the quantity of samples that must be analyzed and the amount of data generated can be daunting regardless of the final drug form, particularly for global companies with multiple production facilities.

The report forecast global Pharmaceutical & Biotechnology Environmental Monitoring market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation.The report offers detailed coverage of Pharmaceutical & Biotechnology Environmental Monitoring industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Pharmaceutical & Biotechnology Environmental Monitoring by geography. The report splits the market size, by volume and value, on the basis of application type and geography.First, this report covers the present status and the future prospects of the global Pharmaceutical & Biotechnology Environmental Monitoring market for 2015-2024.And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].At the same time, we classify Pharmaceutical & Biotechnology Environmental Monitoring according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.Finally, the report provides detailed profile and data information analysis of leading Pharmaceutical & Biotechnology Environmental Monitoring company.

Our exploration specialists acutely ascertain the significant aspects of the global Pharmaceutical & Biotechnology Environmental Monitoring market report. It also provides an in-depth valuation in regards to the future advancements relying on the past data and present circumstance of Pharmaceutical & Biotechnology Environmental Monitoring market situation. In this Pharmaceutical & Biotechnology Environmental Monitoring report, we have investigated the principals, players in the market, geological regions, product type, and market end-client applications. The global Pharmaceutical & Biotechnology Environmental Monitoring report comprises of primary and secondary data which is exemplified in the form of pie outlines, Pharmaceutical & Biotechnology Environmental Monitoring tables, analytical figures, and reference diagrams. The Pharmaceutical & Biotechnology Environmental Monitoring report is presented in an efficient way that involves basic dialect, basic Pharmaceutical & Biotechnology Environmental Monitoring outline, agreements, and certain facts as per solace and comprehension.

Segmentation by Application: Pharmaceutical IndustryBiotechnology IndustryAcademic & Research Institutes

Segmentation by Type: Monitoring EquipmentMediaSoftwareMicrobiology Services

The Essential Content Covered in the GlobalPharmaceutical & Biotechnology Environmental Monitoring Market Report:

* Top Key Company Profiles.* Main Business and Rival Information* SWOT Analysis and PESTEL Analysis* Production, Sales, Revenue, Price and Gross Margin* Market Share and Size

Regional Coverage: North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Colombia etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Some Main Reasons For Purchasing This Report:

Readers of this report will receive in-depth knowledge about the market.

Updated statistics offered on the global Pharmaceutical & Biotechnology Environmental Monitoring market report.

This report provides an insight into the market that will help you boost your companys business and sales activities.

It will help you to find prospective partners and suppliers.

It will assist and strengthen your companys decision-making processes.

Get Full Customize report or for any Special Discount [emailprotected] @ https://www.reporthive.com/request_customization/2501701

Table of Contents

Market Overview: This is the first section of the report that includes an overview of the scope of products offered in the global Pharmaceutical & Biotechnology Environmental Monitoring market, segments by product and application, and market size.

Market Competition by Player: Here, the report shows how the competition in the global Pharmaceutical & Biotechnology Environmental Monitoring market is growing or decreasing based on deep analysis of market concentrate rate, competitive situations and trends, expansions, merger and acquisition deals, and other subjects. It also shows how different companies are progressing in the global Pharmaceutical & Biotechnology Environmental Monitoring market in terms of revenue, production, sales, and market share.

Company Profiles and Sales Data: This part of the report is very important as it gives statistical as well as other types of analysis of leading manufacturers in the global Pharmaceutical & Biotechnology Environmental Monitoring market. It assesses each and every player studied in the report on the basis of main business, gross margin, revenue, sales, price, competitors, manufacturing base, product specification, product application, and product category.

Market Status and Outlook by Region: The report studies the status and outlook of different regional markets such as Europe, North America, the MEA, Asia Pacific, and South America. All of the regional markets researched about in the report are examined based on price, gross margin, revenue, production, and sales. Here, the size and CAGR of the regional markets are also provided.

Market by Product: This section carefully analyzes all product segments of the global Pharmaceutical & Biotechnology Environmental Monitoring market.

Market by Application: Here, various application segments of the global Pharmaceutical & Biotechnology Environmental Monitoring market are taken into account for research study.

Market Forecast: It starts with revenue forecast and then continues with sales, sales growth rate, and revenue growth rate forecasts of the global Pharmaceutical & Biotechnology Environmental Monitoring market. The forecasts are also provided taking into consideration product, application, and regional segments of the global Pharmaceutical & Biotechnology Environmental Monitoring market.

Upstream Raw Materials: This section includes industrial chain analysis, manufacturing cost structure analysis, and key raw materials analysis of the global Pharmaceutical & Biotechnology Environmental Monitoring market.

Marketing Strategy Analysis, Distributors: Here, the research study digs deep into behavior and other factors of downstream customers, distributors, development trends of marketing channels, and marketing channels such as indirect marketing and direct marketing.

Research Findings and Conclusion: This section is solely dedicated to the conclusion and findings of the research study on the global Pharmaceutical & Biotechnology Environmental Monitoring market.

Appendix: This is the last section of the report that focuses on data sources, viz. primary and secondary sources, market breakdown and data triangulation, market size estimation, research programs and design, research approach and methodology, and the publishers disclaimer.

Get Free Sample Copy of this report: https://www.reporthive.com/request_sample/2501701

Why Go For Report Hive Research?Report Hive Research delivers strategic market research reports, statistical surveys, industry analysis and forecast data on products and services, markets and companies. Our clientele ranges mix of global business leaders, government organizations, SMEs, individuals and Start-ups, top management consulting firms, universities, etc. Our library of 700,000 + reports targets high growth emerging markets in the USA, Europe Middle East, Africa, Asia Pacific covering industries like IT, Telecom, Semiconductor, Chemical, Healthcare, Pharmaceutical, Energy and Power, Manufacturing, Automotive and Transportation, Food and Beverages, etc. This large collection of insightful reports assists clients to stay ahead of time and competition. We help in business decision-making on aspects such as market entry strategies, market sizing, market share analysis, sales and revenue, technology trends, competitive analysis, product portfolio, and application analysis, etc.

Pharmaceutical & Biotechnology Environmental Monitoring Market Forecast, Pharmaceutical & Biotechnology Environmental Monitoring Market Trends, Pharmaceutical & Biotechnology Environmental Monitoring Market Research, Pharmaceutical & Biotechnology Environmental Monitoring, Pharmaceutical & Biotechnology Environmental Monitoring Market Analysis, Pharmaceutical & Biotechnology Environmental Monitoring application, Pharmaceutical & Biotechnology Environmental Monitoring Market CAGR Competitive Landscape, Pharmaceutical & Biotechnology Environmental Monitoring Market Growth

Get in Touch with Us :

Report Hive Research

Website: https://www.reporthive.com

Email: [emailprotected]

Speak to Research Analyst: +1-312-604-7084

Read more:
Covid-19 Impact On Pharmaceutical & Biotechnology Environmental Monitoring Market : Growth, Segmentation Analysis By Application And Regions To...

Read More...

Latest Joint Venture Agreements Announced in the Pharmaceutical, Biotechnology and Diagnostic, 2020 – Virtual-Strategy Magazine

October 25th, 2020 5:56 am

DUBLIN, Oct. 20, 2020 The Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2020 report has been added to ResearchAndMarkets.coms offering.

This report provides details of the latest joint venture agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully up to date, the report provides details of joint venture agreements from 2014.

There is an increasing willingness for parties to enter joint venture deals; such deals enable both parties to benefit from the upside of a big product win, whereas traditional licensing deals forfeit upside for near term upfront, milestone and royalty payments.

Joint venture partnering allow the parties to securitize value and reduce risk, but keep a part of the potential upside should the product reach the market. Event if the licensor does not commercialize the project they can either sell those rights to the licensee partner or another partner for an amount higher than would have been achieved at an earlier stage licensing deal.

Another reason for joint venture deals is the joint origin of a project. Drug development projects often require various scientific and technological novelties that stem from different companies. If both companies contributed to the origination of the project, then both have from the beginning a stake in the project.

The report provides a detailed understanding and analysis of how and why companies enter joint venture deals.

Understanding the flexibility of a prospective partners negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of all joint venture deals announced since 2014 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual joint venture contract documents as submitted to the Securities Exchange Commission by companies and their partners.

Contract documents provide the answers to numerous questions about a prospective partners flexibility on a wide range of important issues, many of which will have a significant impact on each partys ability to derive value from the deal.

The appendices to the report includes a comprehensive listing of all Joint venture deals announced since 2014. Each listing is organized as an appendix by company A-Z, stage of development at signing, therapeutic area and industry type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.

The report also includes numerous table and figures that illustrate the trends and activities in Joint venture dealmaking since 2014.

In conclusion, this report provides everything a prospective dealmaker needs to know about Joint venture alliances.

Key benefits

Available deals and contracts are listed by:

Key Topics Covered:

Executive Summary

Chapter 1 Introduction

Chapter 2 Trends in joint venture partnerships2.1. Introduction2.2. Definition of joint venture deals2.3. Success factors for joint venture partnerships2.4. When joint venture partnerships can be useful2.5. Attributes of joint venture partnerships2.6. Aligning partners to make the joint venture work2.7. Trends in joint venture partnerships since 20142.7.1. Joint venture dealmaking by year, 2014 to 20202.7.2. Joint venture dealmaking by stage of development 2014 to 20202.7.3. Joint venture dealmaking by industry sector 2014 to 20202.7.4. Joint venture dealmaking by therapy area, 2014 to 20202.7.5. Joint venture dealmaking by technology type, 2014 to 20202.7.6. Joint venture dealmaking by most active company, 2014 to 20202.8. The future of joint venture partnerships

Chapter 3 Overview of joint venture deal structure3.1. Introduction3.2. Joint venture agreement structure3.3. Example joint venture agreements3.3.1. Case study 1: Agila Specialties Pfenex3.3.2. Case study 2: Dance Biopharm Harmony Asset

Chapter 4 Leading joint venture deals4.1. Introduction4.2. Top joint venture deals by value

Chapter 5 Top 25 most active active joint venture dealmakers5.1. Introduction5.2. Top 25 most active joint venture dealmakers

Chapter 6 Joint venture deals including contracts directory6.1. Introduction6.2. Joint venture deals with contracts 2014 to 2020

AppendicesAppendix 1 Joint venture dealmaking by companies A-ZAppendix 2 Joint venture dealmaking by industry sectorAppendix 3 Joint venture dealmaking by stage of developmentAppendix 4 Joint venture dealmaking by therapy areaAppendix 5 Joint venture dealmaking by technology typeAppendix 6 Joint venture referencesAppendix 7 ResourcesAppendix 8 Deal type definitions

For more information about this report visit https://www.researchandmarkets.com/r/b8myyj

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets Laura Wood, Senior Manager [emailprotected]

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

http://www.researchandmarkets.com

Excerpt from:
Latest Joint Venture Agreements Announced in the Pharmaceutical, Biotechnology and Diagnostic, 2020 - Virtual-Strategy Magazine

Read More...

Is Nantkwest Inc (NK) the Top Pick in the Biotechnology Industry? – InvestorsObserver

October 25th, 2020 5:56 am

Nantkwest Inc (NK) is near the top in its industry group according to InvestorsObserver. NK gets an overall rating of 57. That means it scores higher than 57 percent of stocks. Nantkwest Inc gets a 68 rank in the Biotechnology industry. Biotechnology is number 31 out of 148 industries.

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObservers overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. Theres no need to try to remember what is good for a bunch of complicated ratios, just pay attention to which numbers are the highest.

Nantkwest Inc (NK) stock is trading at $8.10 as of 9:44 AM on Friday, Oct 23, a rise of $0.07, or 0.81% from the previous closing price of $8.04. The stock has traded between $8.08 and $8.44 so far today. Volume today is below average. So far 12,476 shares have traded compared to average volume of 1,109,785 shares.

Click Here to get the full Stock Score Report on Nantkwest Inc (NK) Stock.

The rest is here:
Is Nantkwest Inc (NK) the Top Pick in the Biotechnology Industry? - InvestorsObserver

Read More...

Is Adaptimmune Therapeutics PLC – ADR (ADAP) The Right Choice in Biotechnology? – InvestorsObserver

October 25th, 2020 5:56 am

The 56 rating InvestorsObserver gives to Adaptimmune Therapeutics PLC - ADR (ADAP) stock puts it near the middle of the Biotechnology industry. In addition to scoring higher than 66 percent of stocks in the Biotechnology industry, ADAPs 56 overall rating means the stock scores better than 56 percent of all stocks.

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 56 would rank higher than 56 percent of all stocks.

These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

Adaptimmune Therapeutics PLC - ADR (ADAP) stock is down -2.65% while the S&P 500 is higher by 0.14% as of 11:42 AM on Thursday, Oct 22. ADAP has fallen -$0.12 from the previous closing price of $4.53 on volume of 1,246,466 shares. Over the past year the S&P 500 has risen 14.50% while ADAP is higher by 345.45%. ADAP lost -$1.10 per share the over the last 12 months.

Click Here to get the full Stock Score Report on Adaptimmune Therapeutics PLC - ADR (ADAP) Stock.

More:
Is Adaptimmune Therapeutics PLC - ADR (ADAP) The Right Choice in Biotechnology? - InvestorsObserver

Read More...

Is Aileron Therapeutics Inc (ALRN) Stock Near the Top of the Biotechnology Industry? – InvestorsObserver

October 25th, 2020 5:56 am

Aileron Therapeutics Inc (ALRN) is around the top of the Biotechnology industry according to InvestorsObserver. ALRN received an overall rating of 94, which means that it scores higher than 94 percent of all stocks. Aileron Therapeutics Inc also achieved a score of 100 in the Biotechnology industry, putting it above 100 percent of Biotechnology stocks. Biotechnology is ranked 31 out of the 148 industries.

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 94 would rank higher than 94 percent of all stocks.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObservers overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. Theres no need to try to remember what is good for a bunch of complicated ratios, just pay attention to which numbers are the highest.

Aileron Therapeutics Inc (ALRN) stock is trading at $2.09 as of 10:17 AM on Thursday, Oct 22, a rise of $0.06, or 3.21% from the previous closing price of $2.03. The stock has traded between $2.06 and $2.21 so far today. Volume today is low. So far 240,889 shares have traded compared to average volume of 906,744 shares.

Click Here to get the full Stock Score Report on Aileron Therapeutics Inc (ALRN) Stock.

More:
Is Aileron Therapeutics Inc (ALRN) Stock Near the Top of the Biotechnology Industry? - InvestorsObserver

Read More...

Stem Cells in Regenerative Medicine: The Next Frontier in Biotechnology – The Think Curiouser

October 25th, 2020 5:56 am

The proposed Pre-Loaded Intraocular Lens Market report will encompass all the qualitative & quantitative aspects including the market size, market estimates, growth rates & forecasts & hence will give you a holistic view of the market. The study also includes detailed analysis of market drivers, restraints, technological advancements & competitive landscape along with various micro & macro factors influencing the market dynamics.

The Pre-Loaded Intraocular Lens Market sample report includes an exclusive analysis of COVID-19 pandemic on the market space under scrutiny. The sample represents the format of the overall study which is designed to provide clarity on the structure of the report and some data points demonstrated in an attempt to provide insights into the study quality.

Furthermore, the Pre-Loaded Intraocular Lens Market full research study is designed on account of the fact that each segment is individually assessed and then collated to form the whole market, the study can be tailor-made to fit your exact requirements.

Request Sample Pages of this research study at https://www.theinsightpartners.com/sample/TIPRE00015245/

The structure of the Pre-Loaded Intraocular Lens Market report can be categorized into following sections:

The Prominent/Emerging Players in the Pre-Loaded Intraocular Lens Market Research include:

The Pre-Loaded Intraocular Lens Market Company Profiles are individually represented for all major participants and indices such as Financial Performance, Strategic Initiatives, Product Portfolio & Company Overview.

Company Overview:

Company overview provides the information about location of the company where it is headquartered along with the established year, employee strength as of 2017, regions where the company is operating and the key business areas.

Financial Performance:

Overall company/segment revenue for the year 2019, 2018, and 2017 is provided in the sub title Financial Performance (public listed companies) along with the analysis and explanation of the increase or decrease in the same due to factors such as mergers & acquisition, profit or loss in any strategic business unit (SBUs) and others.

Product Benchmarking:

Product benchmarking comprises the comprehensive list of products pertaining to the respective market along with the application and key features.

Strategic Initiatives:

Insights pertaining to the new product launch, strategic collaboration, mergers and acquisition, regulatory approval, and other developments by the company in market are covered under strategic initiatives section.

Order a copy of this research study at https://www.theinsightpartners.com/buy/TIPRE00015245/

The Pre-Loaded Intraocular Lens Market research study is designed keeping in focus all the major countries. Although, all these countries & their market trends were accounted for while composing it, detailed sections are available for only the spearheads. In case if you would be interested in specific countries which are not covered in the current scope, kindly share the list & we can customize the study based on the geographical scope defined by you.

ABOUT US:

The Insight Partners is a one stop industry research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are specialist in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Our research model is very simple. We believe in client servicing and delivering best quality to our customers. Through our research content, we are making sure that our customers get value of their money along with better quality data and analysis.

Our research content is majorly focused towards market trends in terms of market sizing, competitive landscaping, company analysis, regional or country analysis etc. We provide detailed break-up of segmentation in terms of geography, technology, product and services etc.; which helps our clients to get a deeper analysis on various research topics.About Us:

Contact US:

If you have any queries about this report or would like further information, please contact us:

North America: +1 646 491 9876

Asia-Pacific: +91 20 6727 8686

Email: [emailprotected]

View original post here:
Stem Cells in Regenerative Medicine: The Next Frontier in Biotechnology - The Think Curiouser

Read More...

GAT B 2020 eaxm: Results of Graduate Aptitude Test in Biotechnology released at rcb.res.in – Firstpost

October 25th, 2020 5:56 am

There are a total 1,221 seats available in 62 courses which will be offered to the students who qualify GAT B 2020

The GAT B 2020 result has been declared by the Regional Centre for Biotechnology on its website - rcb.res.in. Candidates who have appeared for Graduate Aptitude Test - Biotechnology (GAT B) 2020 on 3 October can check their rank and scorecard by entering their application sequence number and date of birth.

The GAT B 2020 result will mention details including the name, roll number of the student, marks secured, rank obtained and qualifying status of the candidate.

Those who qualify the entrance exam will get admission in the participating institutes based on the rankings.

A report by Careers 360 said each participating institute releases its GAT B cut off based on different categories of students. There are a total of 1,221 seats available in 24 participating colleges for 62 courses.

Steps to check GAT B 2020 results:

Step 1: Log on to the official website of Regional Centre for Biotechnology - rcb.res.in.Step 2: On the homepage, under Announcement tab, tap on the link that says, 'GAT-B 2020 Rank Card Live'Step 3: You will be directed to a new page where you have to enter your application sequence number and date of birth in DD/MM/YYYY format.Step 4: Press the Login buttonStep 5: Your GAT B 2020 result mentioning your score and qualifying status will be displayed on screenStep 6: Check all the details before saving your GAT B 2020 score card and take a print out

Here is the direct link to check and download GAT B 2020 result: https://cdn.tcsion.com/EForms/configuredHtml/2880/67816/login.html

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

Read more:
GAT B 2020 eaxm: Results of Graduate Aptitude Test in Biotechnology released at rcb.res.in - Firstpost

Read More...

Longevity and Anti-senescence Therapy Market Trend, Industry Analysis, COVID-19 Impact, Growth Rate and Future Forecast 2020-2026 | Top Players:…

October 25th, 2020 5:56 am

LOS ANGELES, United States: QY Research has recently published a research report titled, Global Longevity and Anti-senescence Therapy Market Size, Status and Forecast 2020-2026. This report has been prepared by experienced and knowledgeable market analysts and researchers. It is a phenomenal compilation of important studies that explore the competitive landscape, segmentation, geographical expansion, and revenue, production, and consumption growth of the global Longevity and Anti-senescence Therapy market. Players can use the accurate market facts and figures and statistical studies provided in the report to understand the current and future growth of the global Longevity and Anti-senescence Therapy market.

The report includes CAGR, market shares, sales, gross margin, value, volume, and other vital market figures that give an exact picture of the growth of the global Longevity and Anti-senescence Therapy market.

Competitive Landscape

Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the global Longevity and Anti-senescence Therapy market.

Key questions answered in the report:

TOC

1 Report Overview1.1 Study Scope1.2 Key Market Segments1.3 Players Covered: Ranking by Longevity and Anti-senescence Therapy Revenue1.4 Market by Type1.4.1 Global Longevity and Anti-senescence Therapy Market Size Growth Rate by Type: 2020 VS 20261.4.2 Hemolytic Drug Therapy1.4.3 Gene Therapy1.4.4 Immunotherapy1.4.5 Other Stem Cell Therapies1.5 Market by Application1.5.1 Global Longevity and Anti-senescence Therapy Market Share by Application: 2020 VS 20261.5.2 Hospital1.5.3 Medical Service Institution1.5.4 Drug and Device Sales1.6 Study Objectives1.7 Years Considered

2 Global Growth Trends2.1 Global Longevity and Anti-senescence Therapy Market Perspective (2015-2026)2.2 Global Longevity and Anti-senescence Therapy Growth Trends by Regions2.2.1 Longevity and Anti-senescence Therapy Market Size by Regions: 2015 VS 2020 VS 20262.2.2 Longevity and Anti-senescence Therapy Historic Market Share by Regions (2015-2020)2.2.3 Longevity and Anti-senescence Therapy Forecasted Market Size by Regions (2021-2026)2.3 Industry Trends and Growth Strategy2.3.1 Market Top Trends2.3.2 Market Drivers2.3.3 Market Challenges2.3.4 Porters Five Forces Analysis2.3.5 Longevity and Anti-senescence Therapy Market Growth Strategy2.3.6 Primary Interviews with Key Longevity and Anti-senescence Therapy Players (Opinion Leaders)

3 Competition Landscape by Key Players3.1 Global Top Longevity and Anti-senescence Therapy Players by Market Size3.1.1 Global Top Longevity and Anti-senescence Therapy Players by Revenue (2015-2020)3.1.2 Global Longevity and Anti-senescence Therapy Revenue Market Share by Players (2015-2020)3.1.3 Global Longevity and Anti-senescence Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)3.2 Global Longevity and Anti-senescence Therapy Market Concentration Ratio3.2.1 Global Longevity and Anti-senescence Therapy Market Concentration Ratio (CR5 and HHI)3.2.2 Global Top 10 and Top 5 Companies by Longevity and Anti-senescence Therapy Revenue in 20193.3 Longevity and Anti-senescence Therapy Key Players Head office and Area Served3.4 Key Players Longevity and Anti-senescence Therapy Product Solution and Service3.5 Date of Enter into Longevity and Anti-senescence Therapy Market3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)4.1 Global Longevity and Anti-senescence Therapy Historic Market Size by Type (2015-2020)4.2 Global Longevity and Anti-senescence Therapy Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)5.1 Global Longevity and Anti-senescence Therapy Market Size by Application (2015-2020)5.2 Global Longevity and Anti-senescence Therapy Forecasted Market Size by Application (2021-2026)

6 North America6.1 North America Longevity and Anti-senescence Therapy Market Size (2015-2020)6.2 Longevity and Anti-senescence Therapy Key Players in North America (2019-2020)6.3 North America Longevity and Anti-senescence Therapy Market Size by Type (2015-2020)6.4 North America Longevity and Anti-senescence Therapy Market Size by Application (2015-2020)

7 Europe7.1 Europe Longevity and Anti-senescence Therapy Market Size (2015-2020)7.2 Longevity and Anti-senescence Therapy Key Players in Europe (2019-2020)7.3 Europe Longevity and Anti-senescence Therapy Market Size by Type (2015-2020)7.4 Europe Longevity and Anti-senescence Therapy Market Size by Application (2015-2020)

8 China8.1 China Longevity and Anti-senescence Therapy Market Size (2015-2020)8.2 Longevity and Anti-senescence Therapy Key Players in China (2019-2020)8.3 China Longevity and Anti-senescence Therapy Market Size by Type (2015-2020)8.4 China Longevity and Anti-senescence Therapy Market Size by Application (2015-2020)

9 Japan9.1 Japan Longevity and Anti-senescence Therapy Market Size (2015-2020)9.2 Longevity and Anti-senescence Therapy Key Players in Japan (2019-2020)9.3 Japan Longevity and Anti-senescence Therapy Market Size by Type (2015-2020)9.4 Japan Longevity and Anti-senescence Therapy Market Size by Application (2015-2020)

10 Southeast Asia10.1 Southeast Asia Longevity and Anti-senescence Therapy Market Size (2015-2020)10.2 Longevity and Anti-senescence Therapy Key Players in Southeast Asia (2019-2020)10.3 Southeast Asia Longevity and Anti-senescence Therapy Market Size by Type (2015-2020)10.4 Southeast Asia Longevity and Anti-senescence Therapy Market Size by Application (2015-2020)

11 India11.1 India Longevity and Anti-senescence Therapy Market Size (2015-2020)11.2 Longevity and Anti-senescence Therapy Key Players in India (2019-2020)11.3 India Longevity and Anti-senescence Therapy Market Size by Type (2015-2020)11.4 India Longevity and Anti-senescence Therapy Market Size by Application (2015-2020)

12 Central & South America12.1 Central & South America Longevity and Anti-senescence Therapy Market Size (2015-2020)12.2 Longevity and Anti-senescence Therapy Key Players in Central & South America (2019-2020)12.3 Central & South America Longevity and Anti-senescence Therapy Market Size by Type (2015-2020)12.4 Central & South America Longevity and Anti-senescence Therapy Market Size by Application (2015-2020)

13 Key Players Profiles13.1 CohBar13.1.1 CohBar Company Details13.1.2 CohBar Business Overview13.1.3 CohBar Longevity and Anti-senescence Therapy Introduction13.1.4 CohBar Revenue in Longevity and Anti-senescence Therapy Business (2015-2020))13.1.5 CohBar Recent Development13.2 TA Sciences13.2.1 TA Sciences Company Details13.2.2 TA Sciences Business Overview13.2.3 TA Sciences Longevity and Anti-senescence Therapy Introduction13.2.4 TA Sciences Revenue in Longevity and Anti-senescence Therapy Business (2015-2020)13.2.5 TA Sciences Recent Development13.3 Unity Biotechnology13.3.1 Unity Biotechnology Company Details13.3.2 Unity Biotechnology Business Overview13.3.3 Unity Biotechnology Longevity and Anti-senescence Therapy Introduction13.3.4 Unity Biotechnology Revenue in Longevity and Anti-senescence Therapy Business (2015-2020)13.3.5 Unity Biotechnology Recent Development13.4 AgeX TherapeuticsInc13.4.1 AgeX TherapeuticsInc Company Details13.4.2 AgeX TherapeuticsInc Business Overview13.4.3 AgeX TherapeuticsInc Longevity and Anti-senescence Therapy Introduction13.4.4 AgeX TherapeuticsInc Revenue in Longevity and Anti-senescence Therapy Business (2015-2020)13.4.5 AgeX TherapeuticsInc Recent Development13.5 PowerVision Inc.13.5.1 PowerVision Inc. Company Details13.5.2 PowerVision Inc. Business Overview13.5.3 PowerVision Inc. Longevity and Anti-senescence Therapy Introduction13.5.4 PowerVision Inc. Revenue in Longevity and Anti-senescence Therapy Business (2015-2020)13.5.5 PowerVision Inc. Recent Development

14 Analysts Viewpoints/Conclusions

15 Appendix15.1 Research Methodology15.1.1 Methodology/Research Approach15.1.2 Data Source15.2 Disclaimer15.3 Author Details

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

Here is the original post:
Longevity and Anti-senescence Therapy Market Trend, Industry Analysis, COVID-19 Impact, Growth Rate and Future Forecast 2020-2026 | Top Players:...

Read More...

Virus Purification Kits Market: Consistent Expansion of Biopharmaceutical and Biotechnology Industries Boosts the Global Market – Eurowire

October 25th, 2020 5:56 am

Virus Purification Kits Market: Introduction

Transparency Market Research has published a new report titled Virus Purification Kits Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 20202030. According to the report, the global virus purification kits market was valued at US$ 1.1 Bn in 2019. It is expected to expand at a CAGR of ~11% during the forecast period from 2020 to 2030. Recombinant viral vectors are highly promising tools for both in vitro and in vivo gene transfer, and oncolytic virus show encouraging results for cancer & other related treatment.

Virus purification kits provide fast and simple procedures to concentrate and purify viral vectors from cell lysate and cell culture media. A large number of vaccines are produced from cell-culture derived virus particles. Downstream purification strategies can be expensive and account for 70% of the overall manufacturing costs, which has been fueling the demand for innovative technologies for virus purification in the last few years. North America dominated the global virus purification kits market, in terms of revenue, in 2019. It is expected to continue its market dominance by the end of 2030.

Request Brochure of Report https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=36002

Rise in Research Funding by Public and Private Players to Drive Market

R&D is a vital source of innovation, as it contributes to critical knowledge-based assets as well as strengthens absorptive capacities. Furthermore, an increase in competition in the market is prompting companies to focus on R&D by allocating more resources, both in the form of investments and trained workforce. For instance, Danaher Corporations investment in research & development increased from ~US$ 956 Mn in 2017 to US$ 1.1 Bn in 2019. The higher yield of virus particles received with the help of virus purification kits is also fuelling the global virus purification kits market.

Increase in support from governmental bodies for biotechnology and pharmaceutical industries and consistent expansion of biopharmaceutical & biotechnology industries are major factors driving the global virus purification kits market.

Chromatography to be Lucrative Technology

Based on technology, the global virus purification kits market has been divided into ultracentrifugation, chromatography, nanofiltration, and others. The ultracentrifugation segment dominated the global virus purification kits market due to cost-effective methods and the availability of a large number of products by major companies. Chromatography is likely to be a highly lucrative segment during the forecast period, owing to faster processing time, higher recovery rate of virus, simple methods, and highly purified virus offered by this technology.

Request for Analysis of COVID-19 Impact on Virus Purification Kits Market https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=36002

Adenovirus Dominated Global Market

In terms of virus type, the global virus purification kits market has been segmented into adenovirus, lentivirus, retrovirus, and others. The adenovirus segment accounted for a major share of the market in 2019. It is expected to dominate the global virus purification kits market by 2030. Higher yield of adenovirus particles by latest virus purification kits, major application in viral vector based drugs, and rising incidence of adenoviruses-associated respiratory diseases are key drivers of the segment.

Contract Research Organizations (CROs) to be Promising End User

Based on end user, the global virus purification kits market has been divided into academic & research institutes, biopharmaceutical & biotechnology companies, contract research organizations (CROs), and others. The biopharmaceutical & biotechnology companies segment dominated the global virus purification kits market in 2019 due to the rise in adoption of biotherapeutics across the globe and research activities for drug discovery. Contract research organizations (CROs) is a highly lucrative segment, which is expected to expand at a high CAGR during the forecast period, owing to investments in R&D and initiation of research projects across the globe.

North America to Lead Global Market

In terms of region, the global virus purification kits market has been divided into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for a major share of the global virus purification kits market in 2019, owing to favorable policies & regulatory scenario established by governments for biopharmaceutical industries in the region, highly developed healthcare sector, increase in preference for biopharmaceuticals over conventional counterparts, and continuous evolution of technology. A survey report conducted by Pharmaceutical Researchers and Manufacturers of America (PhRMA) indicated that the total pharmaceutical R&D expenditure in the U.S. was US$ 48.6 Bn in 2011, which increased to US$ 71.4 Bn in 2017. The market in Asia Pacific is projected to expand at a high CAGR during the forecast period due to the expansion of the healthcare sector, growing clinical trials for new drug development, and low cost of products and labor in the region.

Buy Virus Purification Kits Market Report https://www.transparencymarketresearch.com/checkout.php?rep_id=36002&ltype=S

Competition Landscape

The global virus purification kits market is fragmented in terms of number of players with entry of several new players in recent years. Key players in the global market include Merck KGaA, Danaher Corporation, Thermo Fisher Scientific, Inc., Sartorius AG, Lonza Group Ltd., Asahi Kasei Corporation, BioVision Inc., PendoTECH, QIAGEN, and Takara Bio Inc. Mergers, acquisitions & strategic collaborations, and new product & technology launches in recent years have been major strategies adopted by major companies in the virus purification kits market.

More Trending Reports by Transparency Market Research

Erectile Dysfunction Treatment Devices Market: https://www.biospace.com/article/-erectile-dysfunction-treatment-devices-market-lessening-stigma-and-more-awareness-likely-to-drive-the-growth-tmr/

Read our Case study at https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

Read more:
Virus Purification Kits Market: Consistent Expansion of Biopharmaceutical and Biotechnology Industries Boosts the Global Market - Eurowire

Read More...

Top Insights on the Separation Systems for Commercial Biotechnology Market Leading Key Players – TechnoWeekly

October 25th, 2020 5:56 am

Global Separation Systems for Commercial BiotechnologyMarket 2020-2026 Key Challenges. Industry Risks and Worldwide Opportunities during Covid-19.

Market Research Vision published latest Research Report on Global Separation Systems for Commercial BiotechnologyMarket 2020. Research study explores economical impact of pandemic on Separation Systems for Commercial Biotechnologyindustry Segment as follows:

By Important Manufacturers Player 1, Player2, Player 3

Get Latest Sample Report of Global Separation Systems for Commercial BiotechnologyMarket 2020-2026: https://www.marketresearchvision.com/request-sample/543028

The report has segmented market 20202025 into different components on the basis of products, Application, geography and end users wherever needed. With thorough analysis and detailed study of past, present and future market 20162021 conditions, the report is able to delivery factual and reliable information to the users.

By Region / Countries

Click here to Get customization & check discount for the report @ https://www.marketresearchvision.com/check-discount/543028

Our Research Experts have made this insightful report on Separation Systems for Commercial Biotechnologymarket, which is available for user on the site of Market Research Vision. The report carries various factors and elements of the industry in picture, all around the globe, be it its potential or probable threat to its growth or simply the way and method of its functioning during covid-19.

About Market Research Vision

We at Market Research Vision provides a study of products, services, technologies, applications, end users, market dynamics, and market players for global, regional, and country level market segments. Our team widely focuses on market dynamics and identifies new opportunities to rely on. We serve several fortune 500 clients along with various small and large companies. We serve in several domains such as aerospace and defense, automotive and transportation, banking & finance, construction & manufacturing, machinery & equipment, company profiles, consumer goods, food and beverages, ICT media, energy & power, materials and chemicals, medical devices, pharmaceuticals & healthcare, and semiconductor & electronics.

Fill FREE with your queries to get a call from our research expert @https://www.marketresearchvision.com/reports/543028/Separation-Systems-for-Commercial-Biotechnology-Market

Contact Us

Mr. Elvis Fernandes

Phone:

+1 513 549 5911 (US)

+44 203 318 3219 (UK)

Email: [emailprotected]

Read more here:
Top Insights on the Separation Systems for Commercial Biotechnology Market Leading Key Players - TechnoWeekly

Read More...

Turning the Tide – Lifestyle Medicine and change (part 7) – South Coast Herald

October 25th, 2020 5:54 am

Last week we presented common excuses given for why we dont want to commit to changing our behaviour and adopting a healthier way of living.

Today we will cover more ground.

It is true. There are some people who live the most atrociously unhealthy lives who seem to fly under the radar, and escape the bullets. In spite of all odds, they make it to a ripe old age. Good luck to them. But the chance you will do likewise is remote.

ALSO READ : Turning the Tide Top tips on how to change your diet for the better

There are many factors that may have contributed to his longevity genetics, a more active younger life, getting enough sleep at night, a positive attitude towards life, eating some natural whole foods, even if it is a tin of baked beans from time to time. One gets these outliers, who beat the odds.

But instead of stacking up the odds against you, why not try to reduce the risks by whittling away at factors that have been scientifically proven to reduce your health and vitality. And in the process you can reap the rewards of feeling so much better within days of adopting change.

I agree it can be confusing. Author Michael Pollan said Eat food, not too much, mostly plants. Too much of what we eat is food-like substances highly processed edible concoctions that have a long list of very scientific-sounding ingredients. The best foods are the ones that dont have ingredient lists the ones you buy in the vegetable and fruit sections of the supermarket. For thousands of years humankind has thrived on natural foods fruits, vegetables, whole grains, legumes and nuts, seeds and spices. It is only in the last century that the industrial revolution has introduced factory-altered foods to make them more palatable, addictive and provide a longer shelf-life. In doing so our food has lost a great deal of the natural goodness fibre, phytochemicals, vitamins, minerals, etc.

His second point is also relevant not too much. When the food has been so concentrated and titillated, it is easy to over-indulge, resulting in excessive energy intake. This is one of the main reasons for the obesity epidemic.

If we eat mostly plants, we will not be exposed to high levels of saturated fats, and excessive proteins, heme-iron, inflammatory stimulators, hormones and growth stimulators so rife in animal products.

The media loves controversy it sells newspapers/magazines. We love to get good news about our bad habits.

So when some study or article makes claims that support peoples bad habits, even when the study has been sponsored by the industries who benefit most from the recommendations, the headlines are all over the place, creating confusion and controversy. There is more than enough very sound research supporting the simple nutritional information we present in this blog, and which has become imbedded in most of the national guidelines around the world.

There are very many challenges in life. If we want to achieve anything worthwhile we have to make sacrifices and overcome barriers. No success comes easily.

A healthy body, a clear mind, energy for living, and freedom from so many of the scourges of modern life require persistence in small, sustainable changes. We should start slowly, but gradually stretch the limits of our capabilities. You may have pain walking or jogging, but you can strengthen your upper body and torso; you may be able to swim with freedom of pain, or cycle. Where theres a will, theres a way. You may need to counsel with a physiotherapist or a personal trainer, but there are ways you can improve your physical activity.

I hope that the answers you have read to some of the common excuses has given you opportunities to reassess your commitment to change, and think creatively about how you can begin to enjoy the benefits of positive health changes.

Next week we will discuss the SMART pneumonic for implementing changes whether they be with exercise, or dietary changes, or stopping smoking, or dealing with stress in your life.

Until then, contemplate about what you want out of life.

Dave Glass

Dr David Glass graduated from UCT in 1975. He spent the next 12 years working at a mission hospital in Lesotho, where much of his work involved health education and interventions to improve health, aside from the normal busy clinical work of an under-resourced mission hospital. He returned to UCT in 1990 to specialise in obstetrics/gynaecology and then moved to the South Coast where he had the privilege of, amongst other things, ushering 7000 babies into the world. He no longer delivers babies but is still very clinically active in gynaecology. An old passion, preventive health care, has now replaced the obstetrics side of his work. He is eager to share insights he has gathered over the years on how to prevent and reverse so many of the modern scourges of lifestyle obesity, diabetes, ischaemic heart disease, high blood pressure, arthritis, common cancers, etc. He is a family man, with a supportive wife, and two grown children, and four beautiful grandchildren. His hobbies include walking, cycling, vegetable gardening, bird-watching, travelling and writing. He is active in community health outreach and deeply involved in church activities. He enjoys teaching and sharing information.

HAVE YOUR SAY

Like the South Coast Heralds Facebook page, follow us on Twitter and Instagram

See the original post:
Turning the Tide - Lifestyle Medicine and change (part 7) - South Coast Herald

Read More...

Biohacking Conference Kyiv about Efficient Health Optimization Techniques to Take Place on November 11 – Interfax-Ukraine

October 25th, 2020 5:54 am

In the modern world of rapid technological development, you need to do a lot to be successful and stay in the top. It is especially important to know how to stay healthy and enjoy a fulfilling life, be productive and push yourself beyond limits.

Answers to the most topical questions about upgrading the body and mind will be given at the first Biohacking Conference Kyiv, dedicated to innovative ways of improving health and prolonging youth. Organized by Smile-Expo, the event will take place on November 11, 2020.

Leading experts from various industries will speak at the event: doctors, scientists, gerontologists, biohackers and many others. Among them:

- Oleksandr Kolyada geneticist, research associate at the lab of epigenetics at the Institute of Gerontology, founder of DIAGEN lab.

- Lyudmyla Goncharova dietarian, immunologist, two-time winner of The Battle of Nutritionists TV show on STB, founder of Goncharova Clinic.

- Oleksandr Skorokhod Candidate of Biological Sciences, research worker at the Department of signaling cell systems at the Institute of Molecular Biology and Genetics at the National Academy of Sciences of Ukraine.

- Hlib Khodorovskyi meditation expert, experienced mindfulness trainer.

Experts will delve into the main biohacking tools and explain the interrelation of dieting and longevity. Separately, speakers will discuss how genetic researches help to detect health risks, determine parameters of food digestion, and draw up a disease prevention program. In addition, the reports will focus on a safe approach to sports training, the benefits of mindfulness meditations and health management intended to improve productivity in all areas of life.

About safety measures at the conference

To protect guests, speakers, participants, and sponsors of the event against catching coronavirus, Biohacking Conference Kyiv will adhere to all the requirements of the Ukrainian government and the Ministry of Healthcare aimed to prevent the spread of COVID-19.

The following preventive measures will be taken at event, among others:

- Admission to the event is allowed only in a protective face mask or respirator.

- Temperature screening at the entrance.

- Availability of antiseptics in the premises, where the event will take place.

- The number of conference attendees is restricted according to the requirements of the Ministry of Healthcare.

- The distance between chairs for guests will be at least 1.5 meters.

Organizer and venue

The event is organized by the international Smile-Expo company, which specializes in industry events dedicated to innovations.

Biohacking Conference Kyiv will be held at Oasis conference hall on November 11.

More info and registration: kyiv.biohacking.events

Interfax-Ukraine - General News Partner of the event.

See the article here:
Biohacking Conference Kyiv about Efficient Health Optimization Techniques to Take Place on November 11 - Interfax-Ukraine

Read More...

Global Precision Medicine Software Market 2020 Recovering From Covid-19 Outbreak|Know More About Brand Players – The Think Curiouser

October 25th, 2020 5:54 am

The research report entitled GlobalPrecision Medicine SoftwareMarket 2020 added by Syndicate Market Researchprovides professional information to evaluate the most recent Precision Medicine Software market measurements and industry situation. The report offers the research methodology and approaches followed to clear up the Precision Medicine Software industry conditions. This report studies the all-important aspects of the Precision Medicine Software market based on current market conditions and focuses on future possibilities of Precision Medicine Software market during 2020-2026.

This report research enormously examines each and every specific deciding factor of the Precision Medicine Software industry on the basis of present financial condition, Demand, Trends, Limit, Capacity, procedures encapsulated by Precision Medicine Software market competitor and their advancement framework.

Get FREE Sample Copy of Report:https://www.syndicatemarketresearch.com/sample/precision-medicine-software-market

(We Provide Free Sample copy as per your Research Requirement, also including COVID 19 impact analysis)

The research highly targets on the current industry size of the Global Precision Medicine Software market and its improvement capacity on the basis of the last 5 years data with company profile of leading players and manufacturers. The major key regions which add to the progression of Precision Medicine Software market mostly cover such as Precision Medicine Software market in North America, South America, Europe, Africa, the Middle East, and the Asian countries.

Top Players and Manufacturers Analysis in Precision Medicine Software Market:Syapse, Allscripts, Qiagen, Roper Technologies, Fabric Genomics, Foundation Medicine, Sophia Genetics, PierianDx, Human Longevity, Translational Software, Gene42 Inc, Lifeomic Health

Do Inquiry for Purchasing Report Here:https://www.syndicatemarketresearch.com/inquiry/precision-medicine-software-market

This Precision Medicine Software Market report separated into the;1. Top manufacturers2. Product Type (Cloud-based, On-premises)3. Application/ end users (Healthcare Providers, Pharmaceutical and Biotechnology Companies, Research Centers and Government Institutes, Other)4. Key Regions

Key regions covered in the world Precision Medicine Software market report include:

The five regions are in turned segment into major countries and geographies. The key countries included in the global Precision Medicine Software market report includeU.S., Canada, Germany, UK, Italy, France, Spain, China, India, Southeast Asia countries, South Korea, Japan, Australia, GCC countries, Turkey, Brazil, Egypt, Mexico, and South Africa among others.

(Our Analystcan add Regional analysis as per your Research need also)

In the first part, The Precision Medicine Software market report provides company profiling, product picture, contact information and requirements of key producers of the global market. This report comparatively delivers the past, present, and futurist Precision Medicine Software industry strategies, organization capacity, size, share, growth, and forecast analysis be featured the predicted circumstances. Moreover, the possible results and the hazard to the improvement of Precision Medicine Software market comprehensively described in this report.

In next part, the Precision Medicine Software report delivering investigation of the most essential industry players based on their organization profiles, sales volume, Precision Medicine Software market value, yearly income, gross margin, demand and supply is considered in this report, which can drive opportunity Precision Medicine Software market competitors in dynamic business parts of learning.

Browse Complete Report with [emailprotected]https://www.syndicatemarketresearch.com/market-analysis/precision-medicine-software-market.html

Key Highlights of the Precision Medicine Software Market:

Detailed research of the standard Precision Medicine Software market makers can ask the entire market to review the modernize plans and propelling examinations. Centered review of Precision Medicine Software market depends upon expansion, drive confining components and point of speculation can presume the market progress. The investigation of developing Precision Medicine Software market fragment and the dominating business sector will deal with the readers to plan the business strategies. The essential appraisal identified with Precision Medicine Software industry like the cost, sort of uses, the meaning of product, demand, and supply elements are acknowledged in this study report.

In the final part, the Global Precision Medicine Software Market report 2020 portrays business improvement designs, the Precision Medicine Software sales channel, wholesalers, buyers, merchants, studies findings, reference area, measurements sources and more.

Thanks for reading this Report; you can also get specific chapter wise, section wise or region wise reports.

Read another Report:-https://www.openpr.com/news/2160425/global-blockchain-technology-in-healthcare-covid-19

About Syndicate Market Research:

At Syndicate Market Research, we provide reports about a range of industries such as healthcare & pharma, automotive, IT, insurance, security, packaging, electronics & semiconductors, medical devices, food & beverage, software & services, manufacturing & construction, defense aerospace, agriculture, consumer goods & retailing, and so on. Every aspect of the market is covered in the report along with its regional data. Syndicate Market Research committed to the requirements of our clients, offering tailored solutions best suitable for strategy development and execution to get substantial results. Above this, we will be available for our clients 247.

Contact US:

Syndicate Market Research244 Fifth Avenue, Suite N202New York, 10001, United StatesEmail ID:[emailprotected]Website:https://www.syndicatemarketresearch.com/Blog:Syndicate Market Research Blo

Link:
Global Precision Medicine Software Market 2020 Recovering From Covid-19 Outbreak|Know More About Brand Players - The Think Curiouser

Read More...

What’s Behind All the Pro-Azerbaijan Articles? – Armenian Weekly

October 25th, 2020 5:54 am

Azerbaijans President Ilham Aliyev has opened another battlefront thousands of miles away from Baku, in the pages of local and national newspapers and news sites in the US. Much like the Syrian mercenaries Baku recruited and deployed with the help of Turkish defense contractors to target Armenians, Azerbaijans US-based lobbyists are at the forefront of an information warfare that costs millions of dollars annually.

One important aspect of the work of these lobbyists is to place, disseminate and promote anti-Armenian narratives. Their tactics have evolved into a relentless smear campaign through US media outlets, painting Armenia as a close ally of Iran that undermines Western policies and Armenians as intolerant and anti-Semitic. At the same time, Azerbaijan is depicted as a beacon of tolerance, an ally of Israel and a champion of religious rights.

Bakus lobbyists continually push this narrative by placing articles in various media outlets, reaching out to editors with numerous factsheets and disseminating Baku-approved stories to contacts in positions of power. Many such propaganda pieces that are essentially commissioned by the Azerbaijani government appear in US media outlets without proper disclaimers, and therein loom the danger and deception.

Foreign Agents Registration Act (FARA) filings by Azerbaijans lobbyists show how they approach almost every major outlet from Bloomberg to CNN, the Washington Post, the Jerusalem Post, the New York Times, NBC, Al-Jazeera, San Francisco Chronicle, Sacramento Bee, Haaretz, USA Today, and Wall Street Journal; the list is almost interminably long.

Over the past few weeks, numerous articles have discussed Azerbaijans war on Armenia; many have had a bias, some suspiciously so. It may be impossible to tell which are penned by Aliyevs supporters and which are commissioned or disseminated by Bakus agents here; but a few are (and will be) known because of FARA filings.

From comments left under strikingly pro-Azerbaijani articles, it is clear that many readers have been frustrated and disheartened. Arguably, readers have a right to know whether the content they are consuming is either commissioned or part of a foreign governments information warfare. Without proper disclaimers under articles received from embassies by way of lobbyists, editors risk tarnishing the credibility of the news outlets they represent and deliver a blow to the idea of journalistic integrity. A simple one-liner would suffice, such as, This article was sent to us by [insert name of PR firm] on behalf of the Embassy of the Republic of Azerbaijan to the United States of America. Editors uncomfortable with such disclaimers might reconsider running blatant propaganda pieces that essentially import the state-sponsored narrative of a country with one of the worst media freedom records.

To give readers a clearer idea of how Azerbaijans lobbyists place and disseminate narratives that support Bakus propaganda campaign, I will take a close look at the activities of certain lobbyists employed by Aliyevs government, by examining hundreds of pages of FARA filings available in the US Department of Justice (DOJ) online archives.

An Information Warfare

In an Aug. 25 article titled Russia and Irans Dangerous Energy Gambit in the Caucasus and published by the Begin-Sadat Center for Strategic Studies, human rights lawyer and national security analyst Irina Tsukerman embraces all the talking points put out by Baku. She refers to Artsakh as a fake republic and an ersatz entity. After a series of hypotheticals (like Russia and Armenia might join forces to bring Russian biological weapons close to Azerbaijan), she proceeds to advise Baku on how to handle pro-Armenian sentiment in the west.

Azerbaijan should form a closer joint defense relationship with the US, benefiting from joint training and insights from experienced field operatives and officers. Additionally, greater resources need to be marshalled for information warfare and the political aspect of the battle being waged, including supporting professional media to counter disinformation, building personal and long-term relationships with public officials at all levels, and, most importantly, vigorously pursuing legislative and legal relief in US, European, and international bodies. Armenian officials responsible for human rights abuses should be sanctioned, she writes (italics my own).

Since a large chunk of her article deals with the Armenian National Committee of America (ANCA), which is active in DC, one might understand that Tsukerman is essentially encouraging a foreign government, Azerbaijan, to wage information warfare against a grassroots Armenian-American organization that promotes and advocates for the interests of and issues important to American citizens of Armenian origin. In other words, she is calling on Azerbaijan with its dismal media freedom record to export its relentless propaganda to the US.

In its 2020 report, Freedom House designated Azerbaijan as a consolidated authoritarian regime with a score of 10/100, observing that Constitutional guarantees for press freedom are routinely and systematically violated, as the government works to maintain a tight grip on the information landscape. Defamation remains a criminal offense. Journalists and their relatives face harassment, violence and intimidation by authorities. Many have been detained or imprisoned on fabricated charges, while others face travel bans. Armenia fared as partly free, with a score of 53/100. The report noted Independent and investigative outlets operate relatively freely in Armenia, but their work is generally found online.

We may not know what motivates Tsukermans anti-Armenian rhetoric; she has no known ties to current lobbyists for Baku.

On Oct. 20, another one of Tsukermans articles, co-authored by Jason Epstein, was published by Newsweek. Tsukerman and Epstein unite in [their] support of Sunni-majority Turkeys Shia ally, Azerbaijan, an unabashedly pro-Western country, as it is unfairly smeared. The article argues that the war is not about religion; it discusses Azerbaijans secularism, the Popes 2016 visit to Baku, religious minorities in Azerbaijan, and Ashkenazi, Georgian and Mountain Jews.

No wonder Iran, the largest Shia country in the world but with ethnic Azeris comprising of up to 30 percent of its population, feels threatened by a tolerant Azerbaijans continued geopolitical success and therefore supports Armenia, write the authors. Tsukermans co-author Epstein is the president of Southfive Strategies, LLC and a former public relations consultant for the Turkish Embassy in Washington (2002 2007); he has long considered [himself] both pro-Israel and pro-Turkey. Among Southfives past clients are the Azerbaijan Diplomatic Academy in Baku, the Turkish Embassy in Washington and the Turkish Republic of Northern Cyprus Washington office.

Epsteins work with the Azerbaijan Diplomatic Academy, which is funded by the Azerbaijani government, began on Aug. 1, 2008, when Epstein registered as a foreign agent with the DOJs FARA unit for his work with the Academy. In describing his engagement with that entity, Epstein wrote, Assisting the Academy in producing a policy conference in Azerbaijan on US-Azeri relations, as well as meetings with Azeri officials, business leaders, religious leaders, and media personalities.

When asked whether Southfive would engage in political activities and what those activities might entail, Epstein responded, Encouraging journalists to file stories on US-Azeri relations, based on their experiences at the conference and during various meetings.

The disclaimer under the Newsweek article reads: Jason Epstein is president of Southfive Strategies, LLC, an international public affairs consultancy. Irina Tsukerman is a New York-based human rights lawyer and national security/geopolitical analyst, the vice president of Timberwolf Phoenix, a media and security consultancy, and an adviser to the London-based International Justice Organization. The views expressed in this article are the writers own.

There is no mention of Epsteins past lobbying work for the governments of Azerbaijan and Turkey. A reader would have to independently research Southfive Strategies to learn that for years it had engaged in lobbying on behalf of Azerbaijan and Turkey.

Bakus US Agents

A FARA filing by the Podesta Group in 2013 details the extent of its outreach to US politicians, universities, think tanks, but also most major news outlets, including Bloomberg, Foreign Policy, CNN, Washington Post (and Times), EurasiaNet, Associated Press, USA Today, Wall Street Journal, Jerusalem Post, Al-Jazeera, Los Angeles Times, NBC, New York Times and Haaretz.

Just between June and December of 2017, Podesta received $260,735.56 for its work on behalf of the Azerbaijani Embassy in the U.S., according to a Department of Justice (DOJ) report. That year, Podesta was one of four companies registered with the DOJ for work on behalf of Azerbaijan that cost Baku $560,735.56. During a six-month period that same year, 16 companies worked on behalf of Turkey with a total (reported) price tag of $4,284,020.06. Meanwhile, during the six-month period, an Avedis Boyamian offered pro-bono policy consultation to Armenia; price tag: $0. This information is available in the DOJ report titled, Report of the Attorney General to the Congress of the United States on the Administration of the Foreign Agents Registration Act of 1938, as amended, for the six months ending December 31, 2017.

Among the lobby groups that have represented Azerbaijan in the past couple of years are the Livingston Group (contract terminated on Oct. 13), Stellar Jay Communications, BGR Government Affairs, Sanitas International, Rasky Partners (click here for an earlier and more detailed contract, and here and here for samples of their media outreach), and Baker Donelson (contracted by BGR). Meanwhile, another lobbying firm, S-3 Group, which works on behalf of the Baku-based Investment Corporation owned by Seyidov Tural Oglu, has create[d] and place[d] earned and digital media to further diplomacy between America and Azerbaijan, according to a DOJ filing; for instance, S-3 sent out pro-Azerbaijan factsheets on Oct. 15.

To get an idea of the ties, experience and expertise some of these lobby groups retain, a quick glance at the rank and file of BGR Public Affairs will suffice. Among their team members are: former Governor of Mississippi Haley Barbour; former Policy Director at the Senate Finance Committee Matt Hoffmann; Former Representative Sean Duffy (R-WI); former Senior Executive Clandestine Service Officer with the Central Intelligence Agency (CIA) Daniel Hoffman; former FBI man Tom Locke; former US Ambassador to NATO Kurt Volker; former Director of Legislative Affairs for the National Security Council Mark Tavlarides; former senior USAID official Lester Munson; a Frank Ahrens who can arrange client interviews with Fox News, CNN, The Washington Post and major wire services; and a Jeff Birnbaum who is a former White House, congressional and tax reporter for the Wall Street Journal, a senior political correspondent for Time Magazine, Washington bureau chief for Fortune Magazine and a columnist for the Washington Post.

When Azerbaijan and Turkey pay millions to employ such lobbying firms, they are in effect buying ease of access to major national news services.

A Stellar Case

The case of one public relations firm employed by Baku might offer a glimpse into the Azeri lobbying efforts through pro-Azerbaijan articles in US media. The articles pushed on various editors deal with that general theme of tolerant Azerbaijan and intolerant Armenia. Whatever information warfare Tsukerman might have been alluding to in her article is displayed below.

At the center of the story is Jacob Kamaras, the former editor-in-chief of the Jewish National Syndicate (JNS), where pro-Azerbaijan and anti-Armenian articles have appeared in the past two years (for instance, Irina Tsukermans Oct. 12 article), including pieces that promote denial of the Armenian Genocide. Kamaras is the founder and chief of Stellar Jay Communications, which actively lobbied for the Azerbaijani Embassy in the US in 2020, and about which Julian Pecquet, founder and editor of the Foreign Lobby Report, has written. Note that Kamaras has filed a Fictitious Business Name Statement for his company with the DOJ.

Kamaras registered to lobby for the Azerbaijani Embassy on Jan. 31, 2020. The DOJ form informs that the registrant engages with Azerbaijans Ambassador Elin Suleymanov and receives a $3,300 fee per project. Kamaras principal mode of operation is through outreach to newspapers and editors, as noted in another DOJ file. Still another DOJ filing reveals that Kamaras, whose work for the Embassy entailed media consulting and op-ed placement, was paid $56,100 between Feb. 17 and July 10, 2020, presumably for 17 projects.

Among the papers Kamaras submitted to the DOJ are a number of emails he sent to news outlets, urging them to publish certain pro-Azerbaijan articles and offering certain pro-Azerbaijan talking points. There are 14 files (excluding the companys registration) that span the first eight months of the year; the last disclosure is dated August 7.

Propaganda: Israel Should Ally with Tolerant Azerbaijan

In the first email dated Feb. 12, addressed to the editors at the conservative CNSNews.com, Kamaras asks the news website to consider publishing an article by Maayan Hoffman, the news editor at The Jerusalem Post, titled, A Jewish-Muslim paradigm for peace. Hoffman argues that Azerbaijan has pioneered a paradigm for warm Muslim ties with Israel, the nation Tehran repeatedly vows to wipe off the map Israel only stands to benefit from having an ally like Azerbaijan on the border of arguably the Jewish states fiercest enemy. She stresses that Jews live in Azerbaijan in peace and prosperity and details various developments in the benevolent attitude of Baku towards its Jewish minority population.

Kamaras email (like all his other emails discussed below) ends with a disclaimer noting that the email and its contents are sent by Stellar Jay Communications on behalf of the Azerbaijani Embassy.

On Feb. 13, CNSNews published the story, slightly altering the headline to read, Heres What a Jewish-Muslim Paradigm for Peace Looks Like. A brief bio of the author appeared below the article: Maayan Hoffman is news editor and head of online content and strategy at The Jerusalem Post. She has been an American-Israeli international journalist for more than two decades. There was no mention of Stellar Jay Communications or the Azerbaijani Embassy.

Propaganda: Armenia is Anti-Semitic

Kamaras second email dated March 9 is addressed to Rob Shimshock of CNSNews, containing yet another article, this time by Jesse Bogner and titled The old anti-Semitism is alive and well. This piece alleges that there is medieval-style anti-Semitism coming from Armenian organizations and commentators, and that [T]he ANCAs recent rhetoric on Twitter represents the latest indicator of not only the anti-Semitism emanating from Armenia, one of the worlds oldest Christian nations, but also of the disturbing perpetuation of classical Christian anti-Semitism. Of course, Bogner portrays Azerbaijan as a haven of tolerance. By contrast, Armenias Muslim-majority neighbor has a deep relationship with Israel, no history of anti-Semitism, and a prosperous Jewish community of its own for more than two millennia, he writes.

Apparently CNSNews did not publish Bogners article. On March 15, the piece was published on Bogners blog on The Times of Israel. Again, there was no mention of the Azerbaijani Embassy; just Bogners bio: Jesse Bogner is an author and journalist. His memoir and social critique, The Egotist, has been translated into five languages. His work has been featured in The Daily Caller, MSN, The Daily Wire and The Huffington Post. His book of articles, Tikkunim (Corrections), was released in January 2018.

It is outside the scope of this article to counter such propaganda. However, I will refer you to Yoav Loeffs Jan. 27 article titled, Armenias Antisemitism? The Truth Is Different, in The Jerusalem Post, which he wrote coincidentally in response to a piece by Hoffmanthe same Hoffman whose articles Kamaras disseminated on behalf of Azerbaijans Embassy. Loeff, who teaches Armenian history and culture at the Hebrew University of Jerusalem, is Jewish and has traveled to Armenia with other Jews and Israelis on many occasions, and stresses that he has never heard a hint of antisemitic expression.

If there is some criticism, it is usually about Israels hesitation to recognize the Armenian genocide that was perpetrated by the Ottoman Empire he writes.

Armenias small Jewish community never suffered antisemitism in their adopted homeland. Most of them left in the early 1990s, after the severe earthquake in the north of the country in 1988 and the collapse of the Soviet Union, explains Loeff. He notes the dire economic situation following the earthquake and the Artsakh war and adds, They did not leave because they faced any antisemitism; they left because they sought better life.

Loeff also discusses the various ways in which Armenian government representatives had honored Holocaust victims, from Armenian President Armen Sarkissians attendance at the World Holocaust Forum in Jerusalem to the erection of a monument in Yerevan in memory of the victims of the Holocaust and the Armenian Genocide. Unfortunately, there is no parallel such monument in Israel, he adds.

Propaganda: Azerbaijan is a Friend to Israel

On March 13, Kamaras emailed The Jewish Voice editor Fern Sidman, offering him a piece by Hoffman, this time titled, Could fighting coronavirus be the latest frontier in the Israel-Azerbaijan relationship? Hoffman noted the presence of Azerbaijans Finance Minister Samir Shafirov at the AIPAC Policy Conference and quoted him to have said, Cooperation with Israel is not limited to oil supply; we are interested in widening cooperation in defense and the transfer of technology. Apparently Shafirov also read Azerbaijans first-lady-turned-vice-president Mehriban Aliyevas remarks praising Azerbaijani-Jewish ties in the US. The gist of the article was the importance of strengthening Azerbaijani-Israeli ties. The email closed with the usual disclaimer about Kamaras communicating on behalf of the Azerbaijani Embassy.

Hoffmans piece was accepted and published without any mention of Kamaras firm or the Azerbaijani Embassy. However, some days later, NBC news published a piece highlighting Hoffmans article as an example of foreign governments using American lobbyists to promote their efforts to fight the coronavirus outbreak and safeguard their countries reputations in the U.S. capital. NBC goes on to point out that The piece was written by Maayan Hoffman, identified as a Jerusalem Post news editor, but the published version makes no mention that the commentary was placed by Stellar Jay Communications, a lobbying firm representing the government of Azerbaijan, as a FARA filing shows.

NBC was right about foreign governments promoting their countries, safeguarding their reputations and placing op-eds in various papers. What NBC failed to understand is that this was not about the coronavirus, but part of an information war that ultimately feeds and bolsters the myth of the religiously tolerant Azerbaijan and the intolerant Armenia; and that is one of the key objectives of Baku, and by extension their US agents.

Propaganda: Armenia is a Friend to Iran

On April 23, Kamaras sent out another email to CNSNews with an article written by Bogner, whoin Kamaras wordsexamines how the coronavirus is not stopping Iran from fueling conflict and undermining sanctions through its proxies. Specifically, he looks at Armenias role in empowering Iran economically. The article, titled, Coronavirus doesnt stop Iran from fueling the fire of conflict, accuses Iranian trucks of delivering fuel to Nagorno-Karabakh, the Armenian-occupied region which several U.N. resolutions affirm as part of Azerbaijan, charges Armenian banks of enabling Tehran, and faults Democratic US lawmakers for having a pro-Armenian policy agenda.

The article ignores Azerbaijans ties with Iran, the fact that in 2019 Azerbaijans imports from Iran were worth US $452.63 million and exports at US $41.13 million, while Armenias imports from Iran were worth US $324.7 million and exports at US $83.84 million, according to the United Nations COMTRADE database. In other words, both countries maintain an economic relationship with their sanctioned neighbor.

Once again, Bogners piece did not appear in CNSNews and instead was published on his blog on the Times of Israel without any mention of the Azerbaijani Embassy or Jay Stellar Communications.

Propaganda: Azerbaijan Champions Religious Freedom

Kamaras next email (May 6) was also to CNSNews, in which it becomes clear that Rob Shimshock (the recipient) did not respond to the lobbyists previous two emails (which also explains why Bogners pieces ended up on his blog). This time, Kamaras submits his own article titled Azerbaijans postponed Formula 1 race transcends sports about which he tells Shimshock, I write that despite the events postponement this year, the annual Formula 1 auto race hosted by Muslim-majority Azerbaijan particularly during the Islamic holy month of Ramadan is a powerful display of religious freedom, especially in a world plagued by sectarian conflict and now by the invisible enemy of the coronavirus.

What Kamaras fails to mention is that Freedom House gave Azerbaijan a score of 0 out 4 for religious freedom in its 2020 report, which noted, The regime exercises control over religion through state-affiliated entities such as the Caucasus Muslim Board. Religious communities that attempt to operate independently face burdensome registration requirements, interference with the importation and distribution of printed religious materials, and arrest and harassment of religious leaders with international ties or a significant following. In other words, the idea of a religiously tolerant Azerbaijan is a myth nurtured by Bakus agents abroad.

In any case, at the end of the article submission, Kamaras includes his bio: Jacob Kamaras, former editor in chief of the Jewish News Syndicate, is noted for his work on the Middle East and American politics. His writing has appeared in the Washington Times, Independent Journal Review, the American Spectator, and various Jewish and Israeli media. It makes no mention of his role as a lobbyist on behalf of the Embassy of Azerbaijan to the US. However, the email does end with the usual disclaimer.

CNSNews published the article on May 7, slightly altering the title to read, Azerbaijans Grand Prix Transcends Sports, Speaks to Religious Freedom. However, it added the following to Kamaras bio: Jacob Kamaras is founder of Stellar Jay Communications, a PR firm representing Azerbaijan. The next day, another lobbyist on behalf of Azerbaijan, Mark Tavlarides of the BGR Group, emailed the article out to relevant contacts, urging them to read it.

Propaganda: Israel and Azerbaijan are Partners (and Trailblazers in the Understanding of Aging)

A few days later, Kamaras reached out to the editor of the Salinas Californian, Silas Lyons, with a story written by Diana Cohen Altman, former executive director of the Karabakh Foundation and a contributor to the JNS. Altmans piece was about Azerbaijanis who live up to 120 years old in Lankaran. Altman discusses diet, genetics and clusters of very old people in Azerbaijan, as well as longevity in Ashkenazi Jewish populations. Quoted in the piece is a surgeon who is a member of the Azerbaijan-Israel Inter-Parliamentary Work Group. The piece concludes with yet another nod to Azerbaijani-Israeli friendship with these words: Azerbaijan has fostered significant partnerships in the humanities and other disciplines, and the West is building an understanding of Azerbaijani culture and contributions. Amid the pandemic and in the coming years, the U.S. scientific community may look to Israel and Azerbaijan who are partners in technical and other arenas for breakthroughs in the understanding of aging.

The piece did not appear in The Californian. Instead, it was published by The Jerusalem Post on June 4. The final paragraphs were altered a bit, and there was this addition: The Azerbaijani superaging phenomenon may also be of particular interest to social scientists, given major societal changes during the past century. Consider this: Someone over the age of 100 might have witnessed what is now the Republic of Azerbaijan as a portion of the Russian Empire, a part of the early Azerbaijani Democratic Republic, and as an S.S.R. of the Soviet Union. In effect, this addition attempts to insert a historical footnote in this article that on the surface appears to be about longevity.

Altmans bio appears at the end of the piece: Diana Cohen Altman, principal of Cultural Diplomacy Associates, L.L.C., and former executive director of the US cultural non-profit Karabakh Foundation, writes extensively about Azerbaijani cultural and civil-society topics. It made no mention of the Embassy of Azerbaijan or Jay Stellar Communications. Also to note, Altman is still listed on the Karabakh Foundations website as its Executive Director.

Propaganda: Armenians are Intolerant, Anti-Semitic

On June 11, through Kamaras, Baku resorted again to charges of anti-Semitism as a desperate attempt to vilify Armenian Americans. An email informs that Kamaras own article appeared in BreakingIsraelNews (Israel365News.com), titled Armenias Self-Defeating Campaign Against Christians. The article ran as an op-ed. It decried Armenian-American opposition to evangelical pastor Rev. Johnnie Moores support of Azerbaijan and Trumps Middle East policies, singled out Asbarez news for its coverage and bashed the ANCA, accusing it of anti-Semitic tweets.

Although at the base of his email, Kamaras included his disclaimerThis material is distributed by Stellar Jay Communications on behalf of the Embassy of the Republic of Azerbaijan to the United States of Americathe published article made no mention of the authors bio or of his work on behalf of the Azerbaijani Embassy. Readers were (and continue to be) misled into believing the piece was written by a concerned writer and not a paid agent of Azerbaijans propaganda campaign. The Azerbaijani news.az reprinted the article, also without any mention of Kamaras role as a foreign agent for Baku.

Propaganda: Armenia is an Occupier; Unreliable Partner; Aids Iran

On July 14, Kamaras approached The Washington Free Beacon with a list of Azerbaijani talking points on the escalation of violence between Armenia and Azerbaijan. I wanted to share a few angles below that could help you provide broader context in any story, if you choose to pursue one. Should you want to set up a phone interview with the ambassador, please let me know and Ill be happy to arrange it, wrote Kamaras. The Beacon did not take him up on the offer. In fact their last report that even mentions Azerbaijan ran in January of this year. Nonetheless, its worth reviewing Kamaras talking points.

Aside from highlighting some European support for Azerbaijans territorial integrity, Kamaras shared an article by none other than Bogner in American Thinker titled, Democrats West Bank rhetoric rings hollow, in which the author asks, Where is the condemnation of Armenias occupation of the same percentage of internationally recognized Azerbaijani territory, in the Nagorno-Karabakh region?; another article by Paul Miller in the JNS titled, Beware of the sanctions busters, accuses Armenia of offering the [Iranian] mullahs one of their best escape routes from crippling American sanctions; as well as Hoffmans article in BreakingIsraelNews titled, A Nation that is Faithful to Iran Is no Reliable Partner (one can glean the spirit of the article from the title). He also shared a July 7 article in Arab News by Iranian American journalist Adelle Nazarian, a foreign policy analyst with Breitbart News who was in Azerbaijan in 2019. In it, Nazarian argues that Now is the time for US lawmakers to echo Europes support for territorial integrity. Hypocrisy should no longer be accepted.

Propaganda: Armenians are Plagued by Extremist Ideologies(Like Nazism and Anti-Semitism)

On July 13, Kamaras emailed Fox News correspondent Hollie McKay, offering her the opportunity to interview Azerbaijans Ambassador to the US Elin Suleymanov. McKay had interviewed the Ambassador in March 2019. She did not interview the Ambassador in July, but Fox News did speak with him on Sept. 28, just as Azerbaijan launched its offensive. (On Oct. 4 McKay did report on the recruitment of Syrian fighters by Turkish defense contractors to fight in Azerbaijan).

In early August, Kamaras approached a number of news sites on behalf of Amb. Suleymanov. On Aug. 5, he emailed Mercury News asking them to publish an article penned by the Ambassador, titled Hate crimes have no place under the California sun.

The Ambassadors article centers on a scuffle between Armenian and Azerbaijani protesters in Los Angeles. He proceeds to highlight some statements from Jewish American groups regarding the incident and suddenly hurls allegations of anti-Semitism. Both Armenia and the Armenian communities abroad have long been plagued by extremist ideologies, political violence and a complicated history with anti-Semitism, Nazi collaborators and Middle Eastern radicals, he writes.

Such broad charges are not only insulting to Armenians worldwide and Armenian Americans, many of whom fought the Nazis, but also warps history, erasing the sacrifices of many like the members of the Manouchian Group, one of the most active French resistance groups. Of course, this is coming from the representative of a government that wholeheartedly joins neighbor Turkey in its unashamed and continued denial of the genocide perpetrated by its Ottoman Turkish predecessor.

Essentially, the Ambassador is relying on charges of anti-Semitism against Armenians to draw support for the Azerbaijani policies and claims against Artsakh. By doing so, he is using the very real presence and danger of anti-Semitism in the world as a tool to further Bakus agenda and in the hopes of garnering Jewish American and Israeli sympathies. As Kamaras previous emails show, Bakus tactics have at their core the manipulation of fears towards both Iran and anti-Semitism.

The Ambassadors article was presumably rejected by Mercury News, because on Aug. 6 Kamaras submitted the same piece to the San Francisco Chronicle. Three minutes later, he sent the piece to The Sacramento Bee; and a minute later to The Hill. The article was finally published in The Monterey County Herald on Aug. 12, despite its overt propagandizing and vilification of Armenians worldwide.

That is the last of Kamaras activities submitted to the DOJ.

A Glance at BGR

Other lobby groups, such as BGR, also heavily publicized pro-Azerbaijan viewpoints and articles, and reached out to various media outlets for interviews, or to offer talking points. For instance, the DOJ FARA registration unit received a copy of an email from Mark Tavlarides of the BGR Group, which shared an article by the same Nazarian, titled, Azerbaijan: A Nation that Bears the Torch, and Burden, of Bringing Religious Freedom to its Less Tolerant Neighbours in the Region.

The author, Adelle Nazarian, visited Azerbaijans 5th World Forum on Intercultural Dialogue in Baku. Nazarian noted the insightful meetings and visits which left her acutely aware of the sensitive nature of Azerbaijans position as a potential kingmaker for the cause of religious freedom and unity between the three Abrahamic faiths in the region. She expressed hope that religious freedom would also flourish in Azerbaijans neighbors in the region, wrote Tavlarides in his email.

Tavlarides has on many occasions disseminated pro-Azerbaijan articles on behalf of the Embassy, such as a piece by Hoffman in the JNS, titled Azerbaijani national hero provides a paradigm for Jewish-Muslim relations. On numerous other instances, Tavlarides sent out the links to articles, official Azerbaijani statements, resources, factsheets (including an Oct. 5 email), press releases, the pro-Azerbaijan statements of various organizations and politicians, and tweets such as one sent out by Israels Ambassador to the US touting Azerbaijan as a beacon of religious tolerance, as well as another one by Luke Coffey, director of Foreign Policy Studies at The Heritage Foundation, critical of Armenia and Armenians.

In a turn from the cynical to the absurd, Tavlarides also disseminated a link to an episode of the CBS show Seal Team, which depicts the fictional support of elite US forces to help protect an Azerbaijani power plant from a potential attack by Armenian loyalists, Shiite militia, or foreign powers looking to reduce American influence in the region. Tavlarides went on to stress that The scene emphasizes the strategic role of Azerbaijan as our only ally in the Caspian Sea and a deterrent to unaligned powers in the area.

Azerbaijan paid BGR $510,000 in 2019, $600,000 in 2018, and $490,000 in 2017.

The Case of Brenda Shaffer

In 2015, Till Bruckner of the Organized Crime and Corruption Reporting Project (OCCRP) published a piece titled, How to Build Yourself a Stealth Lobbyist, Azerbaijani Style. The focus of the article is Brenda Shaffer, a visiting researcher and adjunct professor at Georgetown University, a Senior Fellow at the Atlantic Councils Global Energy Center, professor at the University of Haifa, and former head of the Caspian Studies Program at Harvard, which was funded by the Azerbaijan Chamber of Commerce. Bruckner discusses Shaffers various activities and lays out her myriad connections with Azerbaijans lobbyists, including her role as adviser to the State Oil Company of the Azerbaijan Republic (SOCAR).

According to Bruckner, Shaffers activities included testifying before the House of Representatives Committee on International Relations, contributing to various DC think tanks (including a panel discussion on Azerbaijan, hosted by the Carnegie Endowment for International Peace, during which she reportedly praised the countrys vibrant press), and writing numerous op-eds for US and Israeli news outlets. She was often consulted on matters relating to Azerbaijanwhether by the media or US officials.

Supported by an overseas regime and an assorted network of overt and undercover lobbyists, she used oil money to build her academic credentials, then in turn used those credentials to promote Azerbaijans agendas through Congressional testimony, dozens of newspaper op-eds and media appearances, countless think tank events, and even scholarly publications, wrote Bruckner.

In a 2006 Harpers Magazine piece titled Academics for Hire, journalist Ken Silverstein wrote, Caspian watchers beware: the next time you see or hear an independent American expert talking about how the regions rulers are implementing bold reforms, check the experts credentials to see just how independent he or she truly is.

After inquiries by Bruckner, some newspapers like The New York Times and The Washington Post added disclaimers under Shaffers articles, disclosing her roles and ties to SOCAR. Others did not.

Shaffer continues to publish op-eds on the subject. For instance, on Oct. 14, JNS ran a piece by Sean Savage titled, How the Armenian-Azerbaijani conflict could impact Israels regional strategic landscape.

Israel and Azerbaijan maintain a strategic alliance. It is not just about arms sales or oil, but a very deep strategic cooperation, she told JNS, adding, Israel has friendly ties with the Armenian people and is home to a vibrant Armenian community. On strategic issues, however, the two states are on different sides. Armenia has close cooperation with Iran, and much of the military supplies to Armenia today transit Iranian territory.

Shaffers credentials were left as a senior fellow at the Atlantic Councils Global Energy Center. The JNS piece was reprinted in multiple outlets.

Armenian Americans Fight Back

The ANCA, the Armenian Assembly and many concerned Armenian Americans have been vocal with their efforts to pressure lobbyists to back down and terminate their contracts, as Foreign Lobbys Pecquet reports. Already over the weekend, the Armenian diaspora bombarded the S-3 Group with more than a thousand emails with an identical message pressuring the Washington public affairs firm to stop representing a new client from Azerbaijan (Foreign Lobby Report was copied on the emails), wrote Pecquet, adding, The firm recently picked up a Baku-based company called Investment Corporation, LLC for $25,000 per month to create and place earned and digital media to further diplomacy. The diaspora letter, which you can read in its entirety here, describes S-3s client as a thinly veiled front for the Government of Azerbaijan through a proxy shell corporation.

Their aim is to vilify Armenians worldwide.

The Livingston Group terminated its contract with the government of Azerbaijan on Oct. 13. Pecquet notes that this came three months after the lobby group informed the DOJ that it was negotiating another contract with Baku. Pecquet also reported that DLA Piper, a lobby group working for the state-owned Azerbaijan Railways CJSC, terminated its contract on Oct. 19. DLA Piper was contracted to provide the foreign principal with legal advice and assistance relating to U.S. sanctions on Iran that affect the transport of oil, gas, and other petrochemical products that originate in third countries and that transit through Iran.

Meanwhile, the lobbying firm Mercury Public Affairs cut its ties with Turkey on Oct. 23, after pressure from the Armenian American community. The decision came following protests led by the ANCA and the Armenian Assembly outside the firms offices, as well as pressure from current clients like Los Angeles County, California State Assembly, and Los Angeles Community College District representatives, reported Politico.

A lot of people have bought a lot of summer homes and fishing boats and put their grandkids through college by lying about Armenia and covering up for Azerbaijan, ANCA Executive Director Aram Hamparian told Politico.

Hamparian said that BGR was next on the list.

Fact: Baku Aims to Vilify Armenians through US Media

Some of the articles disseminated by these lobby groups employed by Azerbaijan cross-link with others written by authors like Bogner, desperately trying to paint Armenia as a threat like Iran, and Armenians as anti-Semites. Reading these articles, one might not even realize that there is a Jewish community in Armenia as well, and they too have spoken up (See Lara Setrakians article in Haaretz titled, Im Jewish and Armenian. Israeli Weapons Are Killing My People). Their existence is not weaponized in western media by either Armenians or the Armenian government.

In all this, it is clear that Azerbaijans smear campaign against Armenia relies on those two tales: Armenia is dangerous; and Armenians are intolerant and anti-Semitic. The basic calculations run something like this: Israel is good; Iran is bad; Armenia is to Azerbaijan what Iran is to Israel; therefore, Armenia must be bad, and Azerbaijan must be good; and furthermore, Israel and Azerbaijan must stand united, while Iran and Armenia are the enemy and must be sanctioned. These are the points that are being pushed by Bakus lobbyists to elicit an unfavorable public perception of Armenia and Armenians. Their aim is to vilify Armenians worldwide. The sheer number of articles pushing this narrative is astounding. Some of them are paid for and disseminated by Azerbaijans lobbyists, and published without any disclaimers to highlight that fact. The propaganda is so blatant that one wonders how anyonewhether readers or editorscould take any of these pieces seriously.

However, the responsibility to vet and flag such articles falls squarely at the feet of editors. By publishing articles without the appropriate scrutiny and disclaimers, editors are complicit in the disinformation campaign and agents of Bakus information war. Mercenaries and lobbyists are motivated by Aliyevs petro-dollars. One can only hope that editors are driven by the pursuit of truth; and those who are not should consider sending their resumes to the Azerbaijani Embassy in DC.

Authors note: Id like to thank Khatchig Mouradian for his feedback. This article does not deal with the activities of lobby groups working on behalf of Turkey, or the financial contributions of Azerbaijans lobby groups to US politicians running for office, or other activities and outreach efforts (such as the Oct. 2 Zoom session with Amb. Suleymanov and congressional staff hosted by BGR), as they are outside the scope of this piece. Those interested can read more about Azerbaijans lobbying efforts at Opensecrets.org, a website that tracks developments in the shady lobbying world.

Nanore Barsoumian was the editor of the Armenian Weekly from 2014 to 2016. She served as assistant editor of the Armenian Weekly from 2010 to 2014. Her writings focus on human rights, politics, poverty, and environmental and gender issues. She has reported from Armenia, Nagorno-Karabagh, Javakhk and Turkey. She earned her B.A. degree in Political Science and English and her M.A. in Conflict Resolution from the University of Massachusetts (Boston).

Continued here:
What's Behind All the Pro-Azerbaijan Articles? - Armenian Weekly

Read More...

Global Precision Medicine Software Market (COVID-19 Analysis) Industry Share, Growth, Trends Analysis Report 2020-26 – The Think Curiouser

October 25th, 2020 5:54 am

In the latest Research Report onGlobalPrecision Medicine Software Market offers an Exclusive Research analysis of the present scenario of the global market.This report contains market revenue, sales, Precision Medicine Software production and manufacturing cost that could help you to get a better view on the market. The Report Focuses on the key global Precision Medicine Software industry manufacturers to describe and analyze the sales volume, value, market share, market competition landscape withSWOTanalysis and development plans in next few years.Major parameters covered under these company profiles include revenues, gross profits, operating income,COGS, EBITDA, sales volume, product offerings, company landscape analysis, key strategic moves, key recent developments, and technological roadmap.Syndicatemarketresearch providesa complete understanding of general market scenarios and future market situations to prepare for rising above the challenges and ensuring strong growth,the complete analysis of Precision Medicine Software Market Size, Data and development forecast from 2020-2026.

Download FREE Sample Report here:-https://www.syndicatemarketresearch.com/sample/precision-medicine-software-market

(We Provide Free Sample copy as per your Research Requirement, also including COVID 19 impact analysis)

The Major Manufactures covered in this Report:-Syapse, Allscripts, Qiagen, Roper Technologies, Fabric Genomics, Foundation Medicine, Sophia Genetics, PierianDx, Human Longevity, Translational Software, Gene42 Inc, Lifeomic Health

Global Precision Medicine Software Market Product and Application Are:-

Product:Cloud-based, On-premises

Application:Healthcare Providers, Pharmaceutical and Biotechnology Companies, Research Centers and Government Institutes, Other

Syndicatemarketresearch analysts covers all key parameters required for COVID-19 effect on business industry, economic implications their trends, factors, consumer behavior on shopping, effect on spending lot of money on advertising and also on useful industries like medical, transportation, food and Beverage.The globally rising of Bio crisis COVID-19 has many businesses are struggling and confused on what steps to take to minimize or maximize the economic impact.

The Global Precision Medicine Software Market Research Report Forecast2020-2026is a valuable source of insightful data for business strategists. It provides the Precision Medicine Software industry overview with growth analysis, historical & futuristic cost, revenue, demand and supply data. The research analysts provide an elaborate description of the value chain and its distributor analysis. This Precision Medicine Software market study provides comprehensive data which enhances the understanding scope and application of this report.

Geographically, Global Precision Medicine Software Market covers:-United States, Europe, China, Japan, India and Southeast Asia and rest of the world

(Our Analystcan add Regional analysis as per your Research need also)

Timeline for Analysis:-

Key Stakeholders

To Get Depth Knowledge about Precision Medicine Software Market Report, Enquiry here:-https://www.syndicatemarketresearch.com/inquiry/precision-medicine-software-market

Key questions answered in this report

The study objectives of this report are:-

Syndicate Market Research provides customization of reports as per your need. The report can be altered to meet your requirements. Contact our sales team, who will guarantee you to get a report that suits your needs.

If you have any special requirements, please let us know and we will offer you the report as you want.

View Customized Full [emailprotected]https://www.syndicatemarketresearch.com/market-analysis/precision-medicine-software-market.html

Read other Report:-https://www.openpr.com/news/2160425/global-blockchain-technology-in-healthcare-covid-19

Contact US:

Syndicate Market Research244 Fifth Avenue, Suite N202New York, 10001, United StatesEmail ID:[emailprotected]Website:https://www.syndicatemarketresearch.com/Blog:Syndicate Market Research Blog

See the article here:
Global Precision Medicine Software Market (COVID-19 Analysis) Industry Share, Growth, Trends Analysis Report 2020-26 - The Think Curiouser

Read More...

AI Medicine Software Industry Market Outlook | Development Factors, Latest Opportunities and Forecast 2025 – The Think Curiouser

October 25th, 2020 5:54 am

Market Study Report, LLC, provides a research on the AI Medicine Software Industry market which offers a concise summary pertaining to industry valuation, SWOT Analysis, market size, revenue estimation and geographical outlook of the business vertical. The study descriptively draws out the competitive backdrop of eminent players driving the AI Medicine Software Industry market, including their product offerings and growth plans.

The latest research report on the AI Medicine Software Industry market assesses the major factors influencing industry growth with respect to the competitive dynamics and geographical reach. It also ensembles the challenges prevalent in this industry vertical and identifies opportunities that will further aid business expansion. Further, the report revisits all areas of the business to cover the impact of COVID-19 pandemic so as to assist stakeholders in devising new strategies and reinforcing their position in the market.

Request a sample Report of AI Medicine Software Industry Market at:https://www.marketstudyreport.com/request-a-sample/2767819?utm_source=thinkcuriouser.com&utm_medium=SK

Key pointers from COVID-19 impact analysis:

Important inclusions in the AI Medicine Software Industry market report:

Ask for Discount on AI Medicine Software Industry Market Report at:https://www.marketstudyreport.com/check-for-discount/2767819?utm_source=thinkcuriouser.com&utm_medium=SK

Regional scope:

TOC of AI Medicine Software Industry Market Report Includes:

The Report Answers the key Questions

For More Details On this Report: https://www.marketstudyreport.com/reports/covid-19-outbreak-global-ai-medicine-software-industry-market-report-development-trends-threats-opportunities-and-competitive-landscape-in-2020

Related Reports:

1. Global Wearable Payment Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)Read More: https://www.marketstudyreport.com/reports/global-wearable-payment-market-report-2020-by-key-players-types-applications-countries-market-size-forecast-to-2026-based-on-2020-covid-19-worldwide-spread

2. Global Home Design Software Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)Read More: https://www.marketstudyreport.com/reports/global-home-design-software-market-report-2020-by-key-players-types-applications-countries-market-size-forecast-to-2026-based-on-2020-covid-19-worldwide-spread

Related Report : https://www.marketwatch.com/press-release/global-multi-screen-content-discovery-engines-market-to-show-strong-growth-at-cagr-of-271-by-2025-2020-10-22

Contact Us:Corporate Sales,Market Study Report LLCPhone: 1-302-273-0910Toll Free: 1-866-764-2150 Email: [emailprotected]

Read more from the original source:
AI Medicine Software Industry Market Outlook | Development Factors, Latest Opportunities and Forecast 2025 - The Think Curiouser

Read More...

Flint children exposed to lead suffer from dental problems, learning disabilities, other issues – MLive.com

October 25th, 2020 5:54 am

FLINT, MI Dachelle McDonalds 10-year-old daughter has had numerous dental visits, a dental operation and teeth that seemed to practically fall out of her mouth without any effort.

McDonald isnt entirely sure any of those issues are related to lead exposure, but her daughter, Neveah Dixon, was drinking the lead-poisoned water just like many others six years ago when Flint changed its water source from treated Detroit Water and Sewerage Department water to the Flint River.

She could just pull her teeth out of her mouth when they started getting loose, McDonald said. It was just weird the way her teeth fell out her mouth.

McDonald remembers her daughter as having issues with her teeth for as long as shes had them.

Her teeth - she always has teeth problems, were always at the dentist, McDonald said. Her skin has two-tone on her face, which is weird because no one in my family, no one has skin like that.

In Flint during the water crisis, the percentage of children with elevated blood lead levels nearly doubled citywide, and nearly tripled among children in high risk areas of lead exposure, according to research by Dr. Mona Hanna-Attisha, the pediatrician credited with exposing the health crisis.

Lead exposure can affect children in different ways, Hanna-Attisha said.

One of the biggest concerns with the water crisis in regard to teeth is the lack of fluoride from not drinking public water, Hanna-Attisha said. Tap water has added fluoride to prevent dental cavities. When people stopped drinking tap water and transitioned to bottled water, they lost fluoride.

Some bottled water has fluoride, but many does not, Hanna-Attisha added.

In late August, state officials announced children 6 years old and younger during the Flint water crisis were the biggest potential beneficiaries of a historic $600 million settlement with the state of Michigan.

How does lead affect children?

According to the Centers for Disease Control and Prevention, exposure to lead can seriously harm a childs health. The adverse effects can include damage to the brain and nervous system, slowed growth and development, learning and behavior problems, and hearing and speech problems.

The health effects can include lower IQ, decreased ability to pay attention, and underperformance in school.

Hanna-Attisha said based on the science of lead, there is no safe level of lead that children can be exposed to.

Its probably the oldest and most well-studied of poisons, Hanna-Attisha said. Weve known about the evil of lead literally for centuries, weve known that lead was bad. Levels that we thought were OK decades ago when we had a lot of lead in paint and gasoline and plumbing - we now know through amazing science and research that theyre no longer OK.

Hanna-Attisha works with Neurodevelopmental Center of Excellence, located inside the Genesee Health System at 420 W. Fifth Ave., to offer assessments to children and individuals impacted by the Flint water crisis.

The big crux of our work, especially with the neurodevelopmental center is to see how kids are doing now and to get them what they need, now, Hanna-Attisha said.

To receive a free and Medicaid covered neuropsychological assessment, the individual must meet several requirements. Visit here to see the list.

Lead in paint, gasoline and plumbing were all banned, starting with gasoline in 1970, leaded-paint in 1978, and lead in plumbing in 1986. However, at the time lead free was defined as solder and flux with no more than 0.2 percent lead and pipes with no more than 8 percent, according to the U.S. Environmental Protection Agency.

Lead is quickly absorbed into the bloodstream. The half-life (time it takes for the amount to decline by 50 percent) of lead in blood is 30 days; some of the absorbed lead is excreted in urine, sweat, and feces. However, some of the absorbed lead is stored in other body tissues, mostly in bone. A persons body burden of lead is the total amount of lead that has accumulated from exposure over time and is stored in the body, said Perri Zeitz Ruckart, health scientist, for Lead Poisoning Prevention and Surveillance Branch, National Center for Environmental Health and Centers for Disease Control and Prevention.

Hanna-Attisha said when issues do present after being exposed to lead, its hard to prove causation.

Its really hard because theres a long time lag of the time from when youve been exposed to when you have a problem. In addition, the problem that you have - say its a learning disability - it can be caused by lots of other stuff too, right?

Hanna-Attisha pointed out issues that stem from lead exposure are multifactorial. Conditions such as poverty, poor nutrition and poor schools can all contribute to learning disability or issue.

Its so important that we have sequential assessments of people so that we can continue to follow folks over time, said Hanna-Attisha. So we can see the potential consequences.

Lead in families

Dixon is a bright, 5-foot-9, intuitive fifth grader at Eagles Nest Academy. Her teachers describe her as a leader in class.

She was 4 years old when the water was switched.

All her blood levels are perfect, shes fine as far as thats concerned. Her teeth - the dentist said it could possibly be that (exposure to lead) but all her blood work says shes fine, so nobody said shes lead poisoned. So, its like how do you determine that? McDonald asked.

In adults, approximately 94 percent of the total body burden of lead is stored in the bones and teeth compared to approximately 73 percent in the bones and teeth of children, according to Zeitz Ruckart.

Bone lead has a half-life of years to decades. Although lead in blood represents only a portion of the total body burden, a blood lead test is the best readily available way to assess a persons exposure to lead, Zeitz Ruckart said.

There are many different factors that affect blood lead levels such as the source of exposure, length of exposure, and underlying susceptibility (childs age, nutritional status, and genetics)," Zeitz Ruckart added. "Even in the absence of exposure, blood lead levels can rise during periods of bone turnover, which include periods of growth, metabolic disease, pregnancy, lactation, osteoporosis.

The issue of lead is a complex issue and often new studies are published that reveal more issues and findings as to how lead works and its harmful effects on humans, according to Hanna-Attisha.

McDonald said she talks to her daughter frequently about the lead situation because she knows its a lot for a child to understand.

She had dental surgery back in 2015, because of all the corrosion in her mouth, McDonald said. They put a lot of caps and stuff in her mouth and a bar.

Hanna-Attisha noted in regard to teeth about national studies that showed kids who drank bottled water had more cavities and worse teeth, but less lead exposure.

Healthy Kids Dental has been in the area for quite some time and it offers free dental care for those who are on Medicaid. The Flint Registry refers kids to Mott Dental as well, according to Hanna-Attisha.

Takisha Moller was pregnant with her daughter Destinee Wilson in 2014, the year the city switched its water supply.

I tasted metal when I was pregnant, like every time the water was boiled, I tasted metal and I told him (Destinees father), I cant drink this water, it tastes like metal. But I kept drinking it, Moeller said. I drank it all the way until they finally said lead was in the water, but that was after she was born.

After Mollers daughter was born she continued to boil the water, just as the city advised, to give her newborn baths.

I was feeding my baby lead all this time, drinking all this water, giving her baths in the lead water and I know it can soak through your skin and all of that so my first thought was: Is her brain going to be OK? Because she lived in my womb for 10 months - I was overdue. I was just worried about her well being and her development and stuff.

When Destinee was three or four months old, Moller remembers the city dropping bottled water off at her home for the family to drink, cook and clean with.

Sometimes I want to ignore it, Moller said of the issues shes noticed in her daughter. Sometimes I want to look past it, but you have to face it.

At nearly 2 years old, Moller observed her daughter wasnt making any strides toward talking. The toddler can be aggressive and she has a learning disability, the mother added.

Its just going to be a watch and wait game, I guess, Moller said as she sighed.

While Moller was growing her baby, fibroid tumors were also growing inside her uterus. The mother of one is scheduled to have a hysterectomy.

So now, I cant have any more kids because Im having a hysterectomy soon. I was just pregnant in February, Moller said. They gave me a surgery a year after Destinee was born to remove some of the fibroid tumors, they took them out but they grew back.

Moller said doctors told her the tumors are related to her drinking the lead water.

I try not to think about it, Moller said before she took a long pause. Im a very positive person. I have been through a lot in my life, so I have learned to take the bad things and spin them into something positive for myself because I understand that no matter what happens, the past is the past and you create your own future.

Lead prevention

Childhood lead poisoning is entirely preventable, according to both Hanna-Attisha and Zeitz Ruckart.

Theres no magical treatment besides prevention, Hanna-Attisha said. So when we realized theres not a magic pill we can give our patients, our focus became: what can we do to limit the impact of this exposure?

The focus of the Neurodevelopmental Center of Excellence studies how learning and behavior are related to brain development and neural networks through comprehensive neuropsychological assessments.

The center is a resource to help with secondary prevention of lead, said Hanna-Atttisha.

Things that help can help with secondary prevention include good nutrition, educational enrichments and mental health support.

Children can be buffered from a lot of those issues if its implemented in their lives, Hanna-Attisha said.

The Flint Registry, a tool built by the community of Flint to connect people to services and programs to promote health and wellness while navigating a health crisis, can provide support for families in those areas.

A partnering program to help provide good nutrition to the families of Flint is the nutrition prescription program, managed by Michigan State University and Hurley Childrens Hospital Pediatric Public Health Initiative, where $15 for healthy foods are prescribed to young patients by their pediatrician.

Chantel Dawson, research assistant for the nutrition prescription program, collects data from the program.

We aim to help individuals maintain a healthy lifestyle - dietary changes, like longevity, Dawson said. So with the program, we provide a prescription for $15, which can be redeemed at the Farmers' Market or it can also be redeemed at our mobile market, which is Flint Fresh.

Dawson said shes noticed more families have been taking advantage of the prescription since the pandemic.

Ive had individuals tell me that they saved it (the prescription) for Thanksgiving and they cooked a healthy Thanksgiving meal with nothing but vegetables, Dawson said. We had individuals even during the pandemic who werent receiving unemployment or any type of food assistance and they were relying on their appointment with their doctor because if they cant go to the clinic, we also offer services via telehealth.

Dawson said one of the things the program has focused on in the last several months is accessibility. The program has now expanded its delivery services outside of Flint and throughout Genesee County.

We are trying to make sure that we give them accessibility still during the hardest times that were going through, Dawson said.

The CDC supports state and local health departments through cooperative agreements to support childhood lead poisoning prevention activities including strengthening: blood lead testing and reporting, surveillance, linking children to recommended follow-up services, and targeted population-based interventions, according to Zeitz Ruckart.

Our work in recovery is holistic, said Hanna-Attisha. Nobody says that this water crisis was just a lead crisis because it it so much more than that. We have been framing everything as a trauma, this was one trauma and really leaning on the science of trauma and being trauma informed and thats kind of driven our holistic science-based community driven response.

Related news:

Leaders urge citizens impacted by Flint water crisis to get help through the Flint Registry

Flint families ponder what the water crisis settlement really means for them

12 critical moments in the history of the Flint water crisis

Original post:
Flint children exposed to lead suffer from dental problems, learning disabilities, other issues - MLive.com

Read More...

Page 337«..1020..336337338339..350360..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick